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Virologic Factors Contributing to the Genetic Diversification of Influenza Viruses
Circulating in North American Swine
Abstract
The purpose of this study was to determine mechanisms of reassortment of swine influenza viruses and
determine if certain reassortant gene combinations can drive evolution and host adaptation in the context
of the triple reassortant internal gene (TRIG) cassette. The TRIG contains a unique combination of a
human polymerase basic 1 (PB1) gene with avian polymerase basic 2 (PB2) and polymerase acidic (PA)
genes. The remaining internal genes, nucleoprotein (NP), matrix (M), and non-structural (NS) are of swine
origin. This differs considerably from classical swine lineage viruses which are drifted variants of the
1918 pandemic with all swine origin genes. We hypothesized that the viruses containing the TRIG
cassette reassort more frequently because the polymerase gene constellation is more promiscuous in its
ability to replicate with novel HA and NA genes. Better understanding of these mechanisms that control
reassortment can be applied to identifying high risk viruses that have an increased ability to reassort and
potentially zoonotically transmit to humans. The segmented nature of influenza viruses provides an
opportunity for gene segment reassortment in which a virus can exchange segments with another virus.
Despite the ability to detect these reassortant viruses, there is little understanding of the mechanisms
that control or drive this process. The first two aims addressed a barrier in the influenza field by
determining what mechanisms restrict reassortment in particular viral genotypes. This can further be
applied to predict the likelihood that other viruses may reassort or be restricted from reassorting. Based
on epidemiologic data not all viruses have the same ability to reassort, thus giving some viruses
particular advantages over others. However, our studies indicated that there are no virologic specific
functions that restrict reassortment, but there are trends demonstrating that the TRIG cassette is more
promiscuous than the classical swine viruses. Thus the propensity of the TRIG viruses to reassert, as
seen in the field, was likely the result of a change in pig farming rather than one particular viral function.
We next assessed the viral fitness of human HA and NA reassortants on both of the swine virus
backbones. There were no observable differences with the human H3 and N2 on either of the swine
backbones when compared to the parental swine backbones. However, we did see some viral fitness
attenuation when the polymerase complex genes were reassorted between the TRIG and classical swine
viruses, suggesting that viral growth efficiency is altered if the polymerase genes and presumable their
interactions are changed. Influenza gene reassortment plays a major role in the evolution of new viruses,
however, it may also drive these reassortant viruses to evolve more quickly and adapt to a new host. The
final aim of the study is evaluated the role reassortment plays in driving host adaption and influenza
evolution. This aim is designed to test a hypothesis derived from natural observations in which avian-like
Eurasian swine virus HAs phylogenetically cluster with increased nucleotide changes in viruses
containing the TRIG NS. We hypothesized that the TRIG and TRIG NS increase the number of nucleotide
mutations in the HA gene resulting in increased viral diversity leading to more rapid host adaptation as
observed by viral fitness in vitro. We found that this evolutionary burst was observed when the TRIG NS is
rescued on the classical swine virus backbone; however it was not seen in a wholly TRIG virus. It is likely
the introduction of a different gene segment that destabilizes the viral genome leading to the observed
evolutionary burst rather than the inherent properties of the TRIG NS. However, this does raise the
concern that reassortment can lead to more rapid host adaption through genetic diversity which could
lead to novel subtypes entering pigs or humans. Of significant concern is that humans are
immunologically naïve to most influenza subtypes. These revelations could help direct the influenza
research community to focus on these particular rapidly evolving viruses that pose the most significant
threat to public and agricultural health.
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ABSTRACT
The purpose of this study was to determine mechanisms of reassortment of swine
influenza viruses and determine if certain reassortant gene combinations can drive
evolution and host adaptation in the context of the triple reassortant internal gene (TRIG)
cassette. The TRIG contains a unique combination of a human polymerase basic 1 (PB1)
gene with avian polymerase basic 2 (PB2) and polymerase acidic (PA) genes. The
remaining internal genes, nucleoprotein (NP), matrix (M), and non-structural (NS) are of
swine origin. This differs considerably from classical swine lineage viruses which are
drifted variants of the 1918 pandemic with all swine origin genes. We hypothesized that
the viruses containing the TRIG cassette reassort more frequently because the polymerase
gene constellation is more promiscuous in its ability to replicate with novel HA and NA
genes. Better understanding of these mechanisms that control reassortment can be applied
to identifying high risk viruses that have an increased ability to reassort and potentially
zoonotically transmit to humans.
The segmented nature of influenza viruses provides an opportunity for gene
segment reassortment in which a virus can exchange segments with another virus.
Despite the ability to detect these reassortant viruses, there is little understanding of the
mechanisms that control or drive this process. The first two aims addressed a barrier in
the influenza field by determining what mechanisms restrict reassortment in particular
viral genotypes. This can further be applied to predict the likelihood that other viruses
may reassort or be restricted from reassorting. Based on epidemiologic data not all
viruses have the same ability to reassort, thus giving some viruses particular advantages
over others. However, our studies indicated that there are no virologic specific functions
that restrict reassortment, but there are trends demonstrating that the TRIG cassette is
more promiscuous than the classical swine viruses. Thus the propensity of the TRIG
viruses to reassert, as seen in the field, was likely the result of a change in pig farming
rather than one particular viral function.
We next assessed the viral fitness of human HA and NA reassortants on both of
the swine virus backbones. There were no observable differences with the human H3 and
N2 on either of the swine backbones when compared to the parental swine backbones.
However, we did see some viral fitness attenuation when the polymerase complex genes
were reassorted between the TRIG and classical swine viruses, suggesting that viral
growth efficiency is altered if the polymerase genes and presumable their interactions are
changed.
Influenza gene reassortment plays a major role in the evolution of new viruses,
however, it may also drive these reassortant viruses to evolve more quickly and adapt to a
new host. The final aim of the study is evaluated the role reassortment plays in driving
host adaption and influenza evolution. This aim is designed to test a hypothesis derived
from natural observations in which avian-like Eurasian swine virus HAs phylogenetically
cluster with increased nucleotide changes in viruses containing the TRIG NS. We
hypothesized that the TRIG and TRIG NS increase the number of nucleotide mutations in
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the HA gene resulting in increased viral diversity leading to more rapid host adaptation as
observed by viral fitness in vitro. We found that this evolutionary burst was observed
when the TRIG NS is rescued on the classical swine virus backbone; however it was not
seen in a wholly TRIG virus. It is likely the introduction of a different gene segment that
destabilizes the viral genome leading to the observed evolutionary burst rather than the
inherent properties of the TRIG NS. However, this does raise the concern that
reassortment can lead to more rapid host adaption through genetic diversity which could
lead to novel subtypes entering pigs or humans. Of significant concern is that humans are
immunologically naïve to most influenza subtypes. These revelations could help direct
the influenza research community to focus on these particular rapidly evolving viruses
that pose the most significant threat to public and agricultural health.
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CHAPTER 1.

INTRODUCTION

Influenza A Virus Classification
Influenza viruses are members of the Orthomyxoviridae family and further
divided into three genera; Influenza A, B, and C. Influenza A viruses are classified based
on the two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA).1
Currently, there are 16 identified HA subtypes and 9 NA subtypes.2-5 Wild aquatic birds
have been identified as the natural reservoir, however, Influenza A viruses infect
numerous hosts, including; ducks, shorebirds, gulls, poultry, pigs, horses, seals, mink,
and humans. Research in host range and restriction has identified species-specific viral
gene lineages, but these lineages are not absolute and viruses have shown the ability to
cross species boundaries.6
Influenza A Virus Structure and Function
Structure and Genome
The influenza virus is enveloped with a genome consisting of 8 segmented
negative-sense RNA strands. Negative-sense RNA must be transcribed in order to
produce cRNA for full length vRNA transcription and mRNA which will be translated
into protein. The envelope consists of a host derived lipid bilayer surrounding the protein
capsid embedded with the HA, NA, and matrix 2 proteins (M2).6,7 The viral capsid is
composed of matrix 1 (M1) protein which surrounds the viral core consisting of the
ribonucleoprotein (RNP) complex.7 The RNP complex is made up of the polymerase
proteins, viral RNA (vRNA), and the nucleoprotein (NP).8 In addition to the polymerase
complex, an alternative open reading frame in some polymerase basic 1 (PB1) proteins,
encodes a truncated protein named PB1-F2. This truncated protein targets the inner
mitochondrial membrane and induces apoptosis.9 The final 2 proteins are the nonstructural protein (NS1) and nuclear export protein (NEP) which are encoded by a single
RNA segment and NS1 is an interferon antagonist while NEP is responsible for
trafficking viral proteins and RNPs out of the nucleus.
Additionally, the segmented genome provides an evolutionary advantage for
influenza viruses. Not only can the viruses evolve through genetic drift, where mutations
accumulate due to the low fidelity of the viral polymerase, but they can also evolve
through reassortment. Reassortment occurs when a cell is “super-infected” with two
viruses and one or more gene segments from one virus are packaged with the remaining
gene segments from the second virus. This is particularly important when the two viruses
are genetically diverse and the surface viral glycoproteins are exchanged, leading to
antigenic shift. Antigenic shifts are the primary modes of pandemic emergence and the
direct result of reassortment.
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Surface Glycoproteins
The two surface glycoproteins, HA and NA, play the crucial roles of receptor
binding and membrane fusion, along with sialic acid cleavage, respectively. The HA
protein is the predominant surface protein with roughly four times as many present
compared to NA.7
Hemagglutinin. The HA protein consists of a homotrimer and is largely regarded
as the primary host determinant factor due to the preference of avian HAs to bind to α2,3
terminally linked sialic acids while mammalian viruses preferentially bind to α2,6 linked
sialic acids.10,11 In addition to binding to sialic acids along the cell surface, HA also
causes membrane fusion between the viral envelope and the endosomal membrane to
release the viral RNP in to the cytoplasm. The inactive from of HA (HA0) consists of a
non-cleaved homotrimer. The HA0 is cleaved by a species specific trypsin-like protease
into HA1 and HA2 which remain connected by a disulfide bond.6 The cleavage is
required for HA activation and infectivity. The globular head of the HA molecule
consists entirely of the HA1 domain and contains the receptor binding site, while the
stalk domain consists of primary HA2 and a small portion of HA1. The stalk domain
contains the proteolytic cleavage sequence which exposes the fusion peptide. Under low
pH conditions, the HA molecule undergoes a significant conformational shift leading to
membrane fusion.7
Neuraminidase. The second major surface glycoprotein is NA which is
responsible for viral spread by cleaving terminal sialic acids and consists of a
homotetramer.6,7 The enzymatic activity of NA provides multiple functions to the
influenza virus. During viral budding from the infected cell, the HA proteins can bind to
target sialic acids, so the NA is required to cleave these targets in order to release the new
virion. Additionally, as new virions bud, their envelope is host derived and contains
terminal sialic acids. The NA activity can prevent aggregation of virions by cleaving the
sialic acids present within the viral envelope thus preventing other virions from binding.
The sialidase activity can also cleave sialic acids present in mucus along the respiratory
tract, which helps to prevent viral inactivation by host defenses.12 All of these roles help
to increase intra-host and inter-host infectivity. Cleaving viral receptors in mucus
increases the virus’ ability to infect cells along the respiratory tract as well as release
virions during sneezing to increase transmission. Similarly, preventing virion aggregation
thereby increasing the distance in which the virus can spread through aerosol droplets to a
new host.
Internal Gene Segments
The 6 internal gene segments encode 8 to 10 proteins including all of the
polymerase proteins, the nucleoprotein, both matrix proteins (one of which is a
transmembrane protein), and the non-structural proteins.
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Polymerase Complex. The influenza A polymerase complex is a heterotrimer
consisting of the polymerase basic protein 2 (PB2), polymerase basic protein 1 (PB1),
and polymerase acidic protein (PA). The polymerase complex is a RNA-dependent RNA
polymerase held together by the PB1 N-terminal interaction with PA and C-terminal
interaction with PB2.13 This complex is responsible for both viral transcription and
replication. To achieve this end, the PB1 protein binds the terminal ends of vRNA, which
causes an allosteric shift in PB2 allowing recognition and binding of host capped premRNAs.14 Binding of vRNA by PB1 also activates endonuclease activity of the PA
protein, which cleaves the 5’ mRNA cap from host pre-mRNAs to use for initiation of
viral transcription.15,16 Some studies also suggest that the PA subunit contains proteolytic
activity of coexpressed proteins to decrease excessive accumulation.17 Additionally, the
PA subunit has been shown to interact with hCLE which is a host gene transcriptional
activator.18
Two other proteins are encoded by the frame shifts in the PB1 and PA reading
frames. These proteins have not been shown to interact with the polymerase complex.
The first identified was the polymerase basic 1 frame 2 (PB1-F2) protein. The PB1-F2
has been shown to localize to the inner mitochondrial membrane and when synthetically
expressed, induces apoptosis.9 It has also been shown to only cause cell death in
monocytes and not epithelial cells when expressed during an influenza infection. The
most recently identified protein is termed the PAX. It has been shown to maintain
endonuclease activity and inhibits host protein expression through host mRNA
degradation.16
Nucleoprotein. The primary role of nucleoprotein is to encapsulate the vRNA.
NP is an arginine-rich monomer, which gives it a net positive charge and allows nonspecific interactions with the negatively charged phosphate backbone of the vRNA.19 By
surrounding the RNA, NP is a key component of vRNA packaging. NP has also been
shown to interact with both PB1 and PB2.20,21 This interaction is likely one method of
regulating the switching of the polymerase activity from mRNA synthesis to vRNA
synthesis.6
Matrix Proteins 1 and 2. The matrix RNA segment encodes two different
proteins in two open reading frames, each with very distinct functions. The M1 protein is
a structural protein that forms the viral capsid, found just beneath the viral lipid envelope.
The M1 protein has two distinct regions, one of which is hydrophobic and inserts itself
into the lipid membrane/envelope and the other region which interacts with NEP and
RNPs.22,23 These interactions are the primary methods in which new virions are
assembled/packaged and the envelope is pinched off as the virion buds.24
The M2 protein is a tetramer that forms a transmembrane ion-channel in the
virion. This ion-channel allows for acidification of the virion core as the endosome
becomes a late endosome. This acidification causes the M1 protein to disassemble and
release the RNP into the cytoplasm in addition to inducing an HA conformational shift to
25
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fuse the membranes.26 Due to the expression and export pathway of the M2 protein, it
also creates a proton channel in the Golgi apparatus, thereby increasing the pH of the
Golgi and preventing premature HA conformational shifts.27
Non-Structural Proteins. NS1 is a highly expressed non-structural protein which
is not incorporated into the virion. Instead of having a role in the virion, NS1 is an
interferon antagonist.7 It accomplishes this through several different pathways. NS1 has
been shown to bind to double-stranded RNA (dsRNA).28 This interaction can sequester
dsRNA from detection by IRF-3 which has been shown to induce activation of IFN-α/β,
which are the primary components of the host innate response to viral infection.29
Additionally, through its dsRNA binding domain, NS1 has been shown to prevent
activation of NF-κB which is also a strong inducer of IFN-α/β.30 These studies have also
demonstrated that without functional NS1, IFN-α/β is not inhibited by influenza virus
infection. Some additional functions attributed to NS1 include; regulation of vRNA
synthesis through interactions with the polymerase complex, enhanced translation of viral
mRNA over host mRNA, blocking the host antiviral response by inhibiting activity of
oligoadenylate synthetase and protein kinase R, and disruption of cellular signaling
pathways by interacting with numerous host proteins through the PDZ domain.31
The NS2 protein is also known as the nuclear export protein (NEP). As mentioned
previously, several studies have shown that NEP interacts with the M1 protein which also
interacts with the RNP complexes.22,32 These interactions occur in the nucleus as new
vRNA is synthesized and needs to be exported to the cell surface in order to be packaged
with newly budding virions. To export the newly synthesized RNPs, NEP binds to the
M1 protein associated with the RNPs and further interacts with human chromosome
region maintenance 1 protein (CRM1).33 Human CRM1 is a highly conserved nuclear
export receptor that mediates export of substrates containing a nuclear export signal from
the nucleus.34 Without the expression of NEP, RNPs localized in the nucleus and did not
produce any viable virus.33
Influenza Virus Lifecycle
As the virus enters a naïve host, the cleaved HA binds to terminal sialic acids on
the cell surface. After binding, the virion is endocystosed and as the endosome acidifies,
the HA complex undergoes a conformational shift in which the hydrophobic fusion
peptide of HA2 inserts itself into the endosomal membrane. After the fusion peptide is
inserted, the HA contracts pulling the viral envelope and endosomal membrane together
resulting in membrane fusion. Additionally, as the late endosome becomes more acidic,
some of the ions enter the virion through the M2 protein ion channel. When the virion
reaches a certain pH, the M1 protein begins to disassemble. This process is coordinated
with the membrane fusion in order to release the viral RNP complexes into the host cell
cytoplasm as illustrated in Figure 1-1.35
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Figure 1-1: Illustration of influenza A lifecycle
Reprinted with permission and under the terms of the Creative Commons Attribution
Non-Commercial License. Squires, B. et al. BioHealthBase: informatics support in the
elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Res
36, D497-503, doi:10.1093/nar/gkm905 (2008).
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The viral RNP complexes are trafficked into the nucleus where the vRNA
segments are transcribed into mRNA by the polymerase complex. These newly
synthesized viral mRNAs are encapsidated by available NP and exported out of the
nucleus where it is then translated into protein by the host ribosome. It is believed that
increased concentrations of NP within the nucleus drives a shift from viral mRNA
transcription to cRNA and vRNA synthesis.6 As vRNA is transcribed, the viral proteins
are also being synthesized with HA, NA, and M2 being processed and exported through
the Golgi apparatus to lipid rafts within the host cell membrane.
As the viral surface glycoproteins and M2 accumulate in lipid rafts, NEP exports
M1 which is bound to RNPs. These complexes are then trafficked to the cell membrane
where the M1 then interacts with the cytoplasmic tails of HA and NA. Studies suggest
that the M1 protein assembles into a capsid structure at the host cell membrane causing
the new virion to bud from the cell as NA cleaves surface sialic acids.6
Influenza A Virus Ecology
The natural reservoirs for all influenza A virus subtypes are migratory waterfowl,
however, a relatively large number of hosts, including; ducks, shorebirds, poultry, pigs,
horses, seals, mink, and humans are susceptible to influenza A virus infection.6 Despite
its ability to infect such a large host range, influenza A viruses are mainly restricted to
either avian or mammalian species, primarily mediated through receptor specificity of
HA.10,11 But, this restriction is far from absolute. Not only can some viruses cross species
barriers, but when avian viruses jump into mammalian species, primarily pigs, they
undergo increased nucleotide substitution rates when compared to viruses which have not
crossed the species barrier.36 In addition to more rapid evolution, the entry of novel
viruses in a new host increases the possibility for reassortment with native viral
populations creating the opportunity to develop novel viral strains with pandemic
potential.37
Over the past century, humans have been infected with relatively few influenza
subtypes, primarily H1N1, H2N2, H3N2, and influenza B. The first human subtype
identified was the H1N1 subtype which emerged as a pandemic strain in 1918. This strain
was initially believed to be a wholly avian virus that evolved the ability to transmit within
mammalian species. However, recent phylogenetic analysis has revealed that the 1918
H1N1 pandemic virus was likely the result of reassortment between different mammalian
viruses.38,39 It was also determined that the HA segment showed mammalian adapted
mutations which had diverged from avian strains, suggesting the virus had circulated in
humans or swine for several years prior to the emergence of the pandemic.40 During the
pandemic, influenza-like-illness (ILI) was observed in U.S. swine herds indicating that
the virus had either transmitted to swine from humans or vice versa.41
Following the 1918 pandemic, the H1N1 subtype remained relatively stable in pig
populations but showed some genetic drift in the human population. Then, in 1957 the
H2N2 pandemic virus emerged. This virus displaced the human H1N1 subtype and is
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believed to be generated by reassortment between the human H1N1 virus which acquired
Eurasian avian lineage H2, N2, and PB1 gene segments.39,42-44 Phylogenetic analysis also
suggests that the avian PB1 and N2 segments had entered the mammalian virus
population several years prior to acquiring the H2 segment. Presumably, the H1N1,
H1N2, and H2N2 viruses co-circulated until the H2 had adequate time to adapt to
mammalian host receptors. Unlike the 1918 H1N1 virus, the 1957 H2N2 virus did not
appear to transmit to swine herds.
Eleven years after the H2N2 pandemic, a novel H3N2 virus emerged as the 1968
“Hong Kong Flu” pandemic strain. Phylogenetic data indicated that the circulating H2N2
virus acquired a novel H3 gene segment and that the two viruses may have co-circulated
for about 2 years prior to the widespread transmission of the pandemic strain and
disappearance of the H2N2 virus.39,45 Due to poor swine surveillance at the time, it is
difficult to determine if the reassortment of these two viruses occurred in swine or
humans, however, the potential for avian and mammalian virus transmission within the
swine host cannot be ignored. As with the H1N1 subtype, the H3N2 virus established a
stable viral lineage within the swine population and the virus was antigenically similar to
the human pandemic strain. However, the prevalence of the H3N2 subtype was
significantly lower than that of the classical swine H1N1 lineage.46 Despite the low level
circulation of H3N2 viruses in swine, the surveillance and phylogenetic information
described above indicates cross species transmission of both mammalian and avian
influenza viruses in swine populations providing an ideal host for reassortment to
continue to occur.
In 1977 the H1N1 genotype virus was isolated from human in China and shortly
after in Russia. This H1N1 virus was widespread throughout the Northern Hemisphere by
1978; however, most of the human population over 20 years of age had been exposed to
H1N1 genotype virus, so the virus was limited in its ability to infect preventing a new
pandemic. Due to the high genetic homology to H1N1 viruses from 1950, the H1N1 virus
isolated in 1977 was likely the result of a laboratory release.47
In 2009, more than 40 years following the H3N2 pandemic, a novel H1N1
pandemic virus emerged. Based on surveillance and sequencing data, this virus has been
determined to potentially be the result of multiple reassortment events. The first
reassortment likely occurred around 1998 in a swine herd located in North Carolina and
the resulting virus circulated to swine herds in Minnesota, Iowa, and Texas. This triple
reassortant virus caused severe ILI in these pig herds. The isolated viruses from these
herds were identified as reassorted H3N2 viruses with HA, NA, and PB1 of human
lineage, NS, NP, and M segments of swine lineage, and PB2 and PA of avian lineage.48,49
This gene clustering of three distinct viral lineages, with avian lineage PB2 and PA
segments, a human lineage PB1 segment, and swine lineage NP, M, and NS gene
segments, is known as the triple reassortant internal gene (TRIG) cassette Table 1-1.
These TRIG containing H3N2 swine viruses further reassorted with H1N1 viruses by
accepting the HA and NA forming two additional distinct subtypes, H1N1 and H1N2.50
Finally, one of the swine viruses reassorted with a Eurasian swine virus and acquired the
Eurasian swine M and NA genes which had not been previously identified outside of
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Table 1-1:

Gene lineage of the TRIG cassette
TRIG cassette
Gene segment
Lineage
PB2
Avian origin
PB1
Human origin
PA
Avian origin
NP
Swine origin
M
Swine origin
NS
Swine origin

Eurasian swine herds.51 This novel H1N1 virus quickly transmitted among the human
population and completely displaced the previously circulating seasonal H1N1 virus.
Subsequently, this TRIG containing virus has been isolated from swine and appears to
continue to reassort.
Influenza A in Swine
Swine are an important host for the maintenance and evolution of influenza
viruses. The emergence and generation of the 2009 H1N1 pandemic virus has been linked
to swine, which have been called a “mixing vessel” for influenza viruses. This is
primarily because the swine respiratory tract contains both the avian influenza virus
receptor α2,3-linked sialic acids and the mammalian influenza virus receptor α2,6-linked
sialic acids. It has also been shown experimentally, that swine can be infected with avian
influenza viruses.52,53
Classical Swine Viruses
Around the time of the 1918 pandemic, the H1N1 virus entered the U.S. swine
population and circulated for roughly 80 years with little antigenic or genetic variation.54
In 1978 a study was completed to determine the prevalence of influenza A viruses within
U.S. swine herds. The study identified a relatively high prevalence of influenza in swine,
about 25% of all swine and up to 47% of particular herds, had been exposed or infected
with the classical swine H1N1 virus which was genetically distinct from the circulating
human H1N1 genotype.46 However, only about 1.4% of the pigs tested had been exposed
to influenza of the H3N2 genotype. H3N2 isolated from swine from 1976-1977 were also
genetically similar to 1975 human isolates, which suggests that they were recent reverse
zoonotic events of the H3N2 viruses rather than sustained in the swine population like the
H1N1 viruses.46 Interestingly, H3N2 viruses were frequently isolated from swine in
Europe and Asia, indicating that the subtype was capable of sustained pig-to-pig
transmission.55 Surprisingly, over 10 years later in 1988/1989, up to 51% of swine herds
in the U.S. were identified as seropositive to H1N1 viruses while only 1.1% had been
exposed or infected by H3N2 viruses.56,57 These surveillance studies illustrate that prior
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to the 1990s the classical swine H1N1 viruses predominated over any other subtype and
the only other influenza viruses that could be identified in swine were human origin
H3N2 subtypes. Despite the low prevalence and few H3N2 swine isolates, the cross
species transmission provided opportunities for reassortment to occur between human
adapted viral strains with the circulating swine influenza viruses.
Swine influenza viruses in the U.S. dramatically changed in the mid to late 1990s.
From 1997-1998, 7.6% of U.S. pigs tested seropositive against avian H1N1 viruses and
8% were seropositive against human H3N2 viruses.58 In August of 1998, there was a
severe outbreak of ILI in swine from North Carolina and subsequent outbreaks on farms
in Minnesota, Iowa, and Texas.48 Swine H3N2 viruses were later isolated in Nebraska,
Colorado, Oklahoma, Wisconsin, and Illinois.49 This outbreak was unique not only that it
was caused by an H3N2 virus, but also it showed increased virulence not previously seen
with classical H1N1 infections. Not only was this a significant increase in swine H3N2
infections, but sequencing analysis of the viruses revealed 3 unique genotypes indicating
that several reassortment events may have occurred. The initial genotype was recovered
from a pig in Ontario and consisted of a wholly human H3N2 virus that appeared to cross
the species barrier but unable to transmit to other pigs.57 The second genotype identified
was a double reassortant virus and contained classical swine PB2, PA, NP, M, and NS
genes with human PB1, HA, and NA genes.48 The third genotype was a triple reassortant
virus with classical swine NP, M, and NS genes, human origin PB1, HA, and NA genes
and avian origin PB2 and PA genes.49 This triple reassortant virus contained and
propagated the TRIG cassette among swine herds in the U.S. and established several new
genotypes within the swine population as seen in Table1-2. A large surveillance study
found that from 1998-2001, out of 3,561 swine samples, 31.7% were influenza positive
among which 77.3% were H1 positive and 22.7% were H3 positive.59 Further
characterization revealed that 67.1%, 4.6%, and 26.9% were positive for H1N1, H1N2,
and H3N2 subtypes, respectively and 1.5% contained H1N1 and H3N2 co-infections.59
Subsequent swine influenza virus surveillance has shown that H1N1 TRIG viruses have
completely displaced the classical swine H1N1 viruses across the U.S. Therefore, these
TRIG containing viruses have a growth advantage over the other genotypes and also can
be maintained within swine herds rather than continued reverse zoonotic events.57 It is
evident that the presence of the TRIG cassette helped the virus sustain transmission
among the swine herds by potentially limiting host restriction through new combinations
of internal genes, or by increasing the reassortment and evolutionary rate, thereby having
a superior gene constellation that allowed it to outcompete the other predominant strains.
TRIG Cassette
Following the introduction of the TRIG cassette in the circulating swine viruses,
additional reassorted viruses discovered were derived from the triple reassortant H3N2
viruses previously mentioned. They contained novel HA and NA genes on the TRIG
backbone. In 1999, an H1N2 virus was isolated from an Indiana farm with a classical
swine H1 and the remaining 7 genes showed sequence homology with the triple
reassortant H3N2 virus, suggesting this was an additional reassortment after the
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Table 1-2:
Gene
segment
PB2
PB1
PA
HA
NP
NA
M
NS

Swine virus gene diversity since 1998
csH1N1
(67.1%)
swine
swine
swine
swine
swine
swine
swine
swine

drH1N1
avian
human
avian
swine
swine
swine
swine
swine

H3N2
(26.9%)
avian
human
avian
human
swine
human
swine
swine

H1N2
(4.6%)
avian
human
avian
swine
swine
human
swine
swine

hH1N1

trH1N2

rhH1N1

human
human
human
human
human
human
human
human

avian
human
avian
human
swine
human
swine
swine

avian
human
avian
human
swine
human
swine
swine

The orange boxes represent gene segments of swine origin. The green boxes show gene
segments of avian origin. The blue boxes indicate human lineage gene segments. The
pink boxes highlight the H3 or N2 gene segments of human origin while the gray boxes
indicate the human H1 or N1 gene segments.
This table was compiled from U.S. swine surveillance studies conducted from 1998 to
2001.
generation of the TRIG cassette (Table 1-2).60 Additionally, in 2004, an H3N1 virus was
isolated from swine in Minnesota with the same TRIG cassette.61
Influenza viruses circulating in swine herds experience little selective pressure
due to the lack of immunity resulting from the short life span of commercial swine, which
is usually only 5 to 6 months.62 Therefore, it is expected that the influenza virus HA
nucleotide substitution rate would be relatively low compared to viruses in the human
population. This was observed up to about 1998; however, with the development of the
TRIG cassette in swine viruses, the rate of antigenic drift as well as shift, or reassortment,
has dramatically increased in the past 10-15 years.63 Specifically, the HA of classical
swine H1N1 from 1930 genetically clusters with more modern classical swine viruses of
1973 despite some genetic drift and also show considerable serologic cross-reactivity.
However, the modern H1 reassortant viruses show distinctly clustered HA sequences and
decreased serologic cross-reactivity with each other and with classical swine HAs when
tested in hemagglutination inhibition assays.50,64 These studies suggest that there has been
considerable drift in swine influenza viruses during the last decade when compared to
classical swine viruses that circulated for roughly 80 years and underwent very little
antigenic drift. Similar data has been reported about the H3N2 triple reassortant viruses
circulating in U.S. swine, yet further surveillance needs to be conducted.64
The reasons for the increased antigenic shift and drift remain largely unclear.
However, there have been several hypotheses, none of which have been thoroughly
explored. First, the TRIG cassette, particularly the combination of human and avian
polymerase genes, is more promiscuous in accepting multiple HAs and NAs. This idea
has clearly been observed in nature and in the laboratory; however, the actual mechanism
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is not defined.65 Secondly, viruses containing the TRIG cassette have a significant growth
advantage over other viruses within swine. This growth advantage not only allowed the
TRIG virus to outcompete the other circulating strains, but also leads to greater genetic
diversity providing greater opportunities to either evade host immune responses or for
generating host adapted mutations. 50 It has been proposed that in addition to having a
greater growth advantage, the TRIG NS gene is more effective at suppressing the initial
host interferon response, therefore allowing a more rapid viral replication after infection
(P. Thomas, personal communication, October 13, 2010). This early rapid viral
replication increases the possibility of mutant viruses emerging and establishing a new
viral subpopulation. This would be observed as an increase in the number of mutants or
the evolutionary rate for TRIG viruses.
The stable circulation of the classical swine H1N1 viruses indicated that it lacked
the ability to successfully reassort despite some low level human H3N2 introduction into
swine. However, after the formation of the TRIG cassette in the mid-1990s, the viral
diversity in swine had significantly increased by 2002. This swine surveillance data
clearly demonstrates a clear advantage of reassortment for viruses that contain the TRIG
cassette when compared to classical swine viruses in the field. This phenomenon was
further demonstrated in the laboratory by coinfecting Madin Darby canine kidney
(MDCK) cells with A/TX/6/1996 (TX/96), a human H3N2 virus similar to H3N2 viruses
isolated from swine in the late 1990s and either A/swine/MN/37866/1999 (MN/99), a
classical swine H1N1 virus, or A/swine/NC/18161/2002 (NC/02), a triple reassortant
swine H1N1 virus that contains the TRIG cassette. Analysis of these samples by reverse
transcription polymerase chain reaction (RT-PCR) revealed that in samples coinfected
with MN/99 and TX/96, 48 samples were positive for the human H3 gene and of the 48,
none were positive for MN/99 PA or PB2 genes.66 Contrastingly, the RT-PCR results of
samples coinfected with NC/02 and TX/96 that of the 38 samples positive for the human
H3 gene, 28.9% contained the NC/02 PA gene and 52.6% contained both of the NC/02
PB2 and PA genes.66
This experiment demonstrated that MN/99 lacks the ability to successfully acquire
the human H3 gene and produce viable virus. It also supports the surveillance data of
swine influenza viruses prior to 1998. However, the NC/02 triple reassortant virus
showed an increased propensity to acquire the human H3 gene under multiple conditions,
similar to what was observed with swine viruses once the TRIG cassette was introduced
in the viral population around 1998.
Research Aims
In the last 10-15 years, swine influenza viruses in the U.S. have proven to be
rapidly evolving through genetic drift and shift compared to what was seen in the
previous 80 years. This increased genetic drift and shift corresponds with the formation
of the TRIG cassette in U.S. swine. However, there is little laboratory evidence for why
the TRIG is not only more promiscuous in its ability to replicate and transmit with novel
HA and NA gene segments, but also what virologic factors contribute to observed
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increased nucleotide substitutions. These observations helped to formulate the following
3 hypotheses.
Hypothesis 1
Viruses including influenza virus have shown the ability to prevent additional
viruses from infecting the same cell. The classical swine influenza viruses have the
ability to more effectively exclude a second virus from infecting the same cell when
compared to the swine viruses which contain the TRIG cassette.
Hypothesis 2
TRIG containing viruses have shown an increased propensity to grow with a
variety of HA and NA combinations compared to what was seen with classical swine
viruses. Therefore, the TRIG viruses must reassort more readily and following
reassortment produce progeny virions with sufficient growth advantages to compete with
the parental genotypes and transmit to naïve hosts.
Hypothesis 3
Phylogenetic analysis of influenza viruses in nature with the TRIG and with the
TRIG NS have shown increased nucleotide substitutions in the HA, suggesting they
evolve more rapidly. If this is a purely virologic aspect, then viruses rescued on the TRIG
backbone or with the TRIG NS should show increased nucleotide substitutions in rescued
viruses.
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CHAPTER 2.

INFLUENZA VIRUS SUPERINFECTION EXCLUSION AND
GROWTH KINETICS OF REASSORTANTS
Introduction

Reassortment plays a crucial role for influenza virus adaptation and evolution.
However, the mechanisms that govern reassortment are poorly understood. This includes
the ability to accept new genes as well as the frequency in which new gene combinations
arise. The classical swine H1N1 viruses remained genotypically stable for about 80 years.
However, once the TRIG cassette was formed and propagated within the swine viral
population, the rate of reassortment greatly increased. Suggesting there is some inherent
property of the TRIG gene arrangement that allows it to more readily acquire new HA
and NA genes when compared to the classical swine gene constellations.
In order for reassortment to occur, a single cell must be infected with at least two
viruses, also known as superinfection. The NA of influenza viruses may play a role in
preventing superinfection by cleaving sialic acid receptors off the cell surface as it is
expressed.67 Plasmid expression of NA in cells resulted in the release of sialic acids from
the cell surface, prevented HA mediated viral entry, and in the presence of NA inhibitors
more cells were superinfected with H1 and H3 viral subtypes. This viral exclusion also
prevents reinfection of the cell by new budding virions. Other viruses have also been
shown to possess unique mechanisms to prevent superinfection by reducing expression of
the viral receptors or inducing internalization of viral receptors.68,69
Previous experiments have shown that NC/02 is able to reassort with the human
H3N2 virus, TX/96, while the classical swine MN/99 lacks the ability to reassort.
Therefore, it is hypothesized that the MN/99 virus is able to more efficiently exclude
another virus from superinfection compared to NC/02. This would greatly reduce the
possibility of the MN/99 virus producing reassortant progeny. This will be tested using
fluorescently labeled monoclonal antibodies specific for H1 or H3 to quantify the number
of superinfected cells during simultaneous or delayed infections.
Not only do cells have to be superinfected in order for reassortment to be a
possibility, but the progeny virions must be of sufficient fitness to compete with or
outcompete the parental strains. This led the hypothesis that if superinfection exclusion is
not responsible for the differences between MN/99 and NC/02 in their ability to reassort,
then the 80 years of MN/99 evolution created an optimized and stable gene constellation
in which reassorting with human virus gene segments does not produce progeny with the
growth properties required to outcompete the parental strains. Growth kinetics will be
completed for these viruses including reverse genetic reassortants to determine if the
addition of the human HA and NA on the swine backbones causes any attenuation.
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Materials and Methods
Viruses
For flow cytometry two reverse genetics (RG) viruses RG-MN/99, a classical
swine H1N1 virus with all 8 gene segments of swine origin lineage, and RG-NC/02, a
triple reassortant H1N1 virus with the TRIG cassette and swine origin HA and NA genes,
and one wild type virus TX/96, a human seasonal H3N2 virus with all 8 gene segments of
human lineage origins, were used for the following experiments. The RG viruses were
generated using the dual promoter eight plasmid system as outlined in Figure 2-1.70
Briefly, the RNA is extracted from the virus of interest and is amplified by RT-PCR. The
amplified gene segments are purified, digested with BsmBI, BsaI, or AarI and then
ligated into the pHW2000 plasmid. All 8 plasmids are then simultaneously transfected
into a 90-95% confluent MDCK-293T cell co-culture using TransIT-LT1 (Mirus catalog
number MIR 2304). The rescued virus supernatants are then injected into 10 day old
embryonated chicken eggs and incubated at 35°C for 48 hours. The allantoic fluid is
harvested and re-injected into embryonated chicken eggs for a second passage. The virus
is harvested, aliquoted, and stored at -80°C. Each vial is only thawed once before use in
each experiment.
For the growth kinetics experiments reverse genetics viruses were rescued by
adding the human H3N2 viral glycoproteins on both of the swine backbones (Table 2-1).
The MN/TX genotype consists of the human H3 and N2 from TX/96 with the remaining
6 gene segments from the MN/99 virus. The NC/TX virus contains the TRIG cassette
with the human H3 and N2 derived from TX/96.
Coinfection
MDCK cells were grown to about 80-90% confluency in a 24-well tissue culture
plate. Prior to infection, one well was trypsinized and cells were counted using the
Invitrogen Countess (catalog number C10227). Cells were infected at multiplicities of
infection (MOI) of 0.01 and 1, based on the live cell counts as outlined. For simultaneous
infection times, the desired amounts of NC/02+TX/96 and MN/99+TX/96 were mixed
prior to addition to the cells. For delayed infections, each virus, NC/02, TX/96, or MN/99
were added at time point 0. These infections were incubated at 37°C with 5% CO2 for 1
hour and then the viral dilutions were washed from the cells using sterile PBS (pH 7.4).
Following the wash, infection media (1X minimum essential media (MEM)
supplemented with antibiotics (Gibco catalog number 15240-062), vitamins (Gibco
catalog number 11120-052), 400 µM glutamine (Gibco catalog number 25030-081),
0.1% BSA (Sigma catalog number A8412), and 0.5 µg/ml TPCK-Trypsin) was added and
incubated at 37°C with 5% CO2 for 24 hours. At 24 hours post infection (hpi),
supernatants were aspirated from the cells and for single and simultaneously infected
cells, new infection media was added. For the 24 hour delayed infections, the infection
media contained the second virus to be added at the proper MOI dilution and plates were
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Figure 2-1: Illustration of the dual promoter eight plasmid system to rescue
cloned viruses
A) Viral RNA is extracted, reverse transcribed, and then amplified using RT-PCR. All 8
of the amplified dsDNA influenza segments are digested using BsmBI, BsaI, or AarI, and
ligated into the plasmid pHW2000 directly between the human Pol I promoter and pol I
terminator, both of which are flanked by the CMV promoter and the BGH
polyadenylation signal. B) The cloned influenza gene segments in the pHW2000
expression vector are transfected into confluent MDCK and 293T cell monolayers and
incubated at 37°C with 5% CO2 for 72 hours. The 293T cells produce the initial virions
which can infect and replicate in the MDCK cells.
Reprinted with permission by the National Academy of Sciences, U.S.A. and Dr. Robert
Webster. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A
DNA transfection system for generation of influenza A virus from eight plasmids. Proc
Natl Acad Sci U S A 97, 6108-6113, doi:10.1073/pnas.100133697 (2000). Copyright
2000 National Academy of Sciences, U.S.A.
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Table 2-1:

Rescued virus gene compositions
Gene segment source

RG-virus
abbreviation

PB2

PB1

PA

HA

NP

NA

M

NS

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

MN/99

MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99

TX/96*

Wild Type

NC/TX 6+2

NC/02

NC/02

NC/02

TX/96

NC/02

TX/96

NC/02

NC/02

MN/TX 6+2 MN/99 MN/99 MN/99

TX/96

MN/99

TX/96

MN/99 MN/99

The orange boxes indicate gene segments from the TRIG swine virus NC/02. The blue
boxes indicate gene segments of classical swine lineage from MN/99 and the green boxes
are genes derived from the human H3N2 virus, TX/96.
* TX/96 is a wild type virus and only HA and NA were cloned for rescue on the swine
viral backbones.
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incubated at 37°C with 5% CO2 for 1 hour followed by aspiration of the virus supernatant
and addition of fresh infection media.
Antibody Purification and Fluorescent Labeling
Anti-H1 and anti-H3 antibodies were identified using hemagglutination inhibition
assays that specifically targeted the NC/02, MN/99, and TX/96 viruses and to confirm
these antibodies did not non-specifically bind to the alternate subtype. The antibodies
were purified from the ascites fluid as outlined in Appendix A. Briefly, the lipid content
is removed from the ascites fluid using PHM-L Liposorb (EMD Millipore catalog
number 524371) and the monoclonal antibody is bound by a 1 ml HiTrap Protein G
column (GE Healthcare catalog number 17-0404-01). The column is washed with PBS
until the flow through contains no detectable protein contamination as determined by
absorbance reading at 280 nm (A280) less than 0.002 as determined by a NanoDrop 1000
spectrophotometer instrument. Then the antibody is eluted using an acid buffer into 1 ml
fractions and only fractions containing protein as determined by A280 readings are
pooled and desalted using a Zeba spin 7K MWCO, 2 ml spin desalting column (catalog
number 89889). The final concentration of the IgG was determined by a NanoDrop 1000
instrument and directly labeled.
The purified anti-H1 and anti-H3 antibodies were fluorescently labeled with
Alexa Fluor 488 (Invitrogen catalog number A20181) and Alexa Fluor 555 (Invitrogen
catalog number A20187), respectively. The antibodies were diluted to 1 mg/ml in 1 ml
and added 100 µl of 1 M sodium bicarbonate. To the provided reactive dye vial, 100 µl of
the antibody dilution was added. This was gently inverted on a rocking plate for 1 hour at
room temperature. This solution was then added to a prepared ~1.5 ml purification resin
column and centrifuged at 1100 x g for 5 min. The eluent is labeled antibody in 1X PBS
at a pH of 7.2 with 2 mM sodium azide.
Flow Cytometry
The infected MDCK monolayer was washed with PBS and trypsinized and moved
to a 96 well plate. The cells were stained with either Alexa Fluor 488 conjugated anti-H1
antibody or Alexa Fluor 555 conjugated anti-H3 antibody or both. The stained samples
were analyzed on a BD FACS Canto II.
Growth Kinetics
To an 80% confluent monolayer of MDCK cells, the RG viruses and wt TX/96, as
outlined in Table 2-1, were used to infect at MOIs of 0.01. MOIs were calculated by
counting trypsinized cells using the Countess cell counter (Invitrogen catalog number
C10227). The viruses were diluted in infection media to the appropriate MOI and added
to the cell monolayers and incubated at 37°C with 5% CO2 for 1 hour. Cell monolayers
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were then washed with 1X PBS and infection media was added to the washed cells. For
the MDCK growth kinetic experiments, 2 x 100 µl samples were collected at the
following time points, 6, 8, 10, 12, 20, 24, 36, and 48 hpi. All of the samples collected
were stored at -80°C until viral TCID50 titers could be determined. All TCID50 titers were
determined using MDCK cells by making 10 fold dilutions of each time point and
infecting a single well of a 96 well plate with one dilution. Each time point was measured
in quadruplicate using 0.5% (v/v) turkey red blood cells in PBS. To maintain continuity,
the samples did not undergo any freeze-thaw cycles prior to titration. Significance was
calculated using a 2way ANOVA analysis.
Results
Coinfection Exclusion
As influenza viruses replicate, HA is expressed on the surface of the infected cell,
which is incorporated into budding virions. Using fluorescent antibodies targeted to these
HA molecules allowed us to identify H1 and H3 infected cell and quantify the amount of
cells that were infected by either NC/02, MN/99, or TX/96 as well as those infected by
both an H1 and an H3 virus. These experiments were designed to determine if MN/99 is
more capable of excluding superinfection when compared to NC/02, explaining the lack
of reassortment observed between MN/99 and TX/96.
Simultaneous infections at an MOI of 0.01 revealed that nearly 3 times fewer cells
were coinfected between MN/99 and TX/96 (8.8%) when compared to NC/02 and TX/96
(26.1%) (Figure 2-2A and B). Nearly half of these cells were infected with the MN/99 or
NC/02 viruses and very few were infected with the TX/96 virus (Figure 2-3). When the
TX/96 infection is delayed by 24 hours after the initial infection with MN/99 or NC/02,
0% to 0.3% of the cells, respectively, stained positive for TX/96 infection while over half
of the cells were infected with MN/99 (69.7%) and nearly all of the cells were infected
with NC/02 (92.7%) (Figure 2-2C and D). Similar results were observed when the
MN/99 or NC/02 swine viruses are delayed 24 hours after the TX/96 infection. The
percentage of coinfected cells ranged from 0.2% when NC/02 is delayed to 0.3% when
MN/99 was delayed (Figure 2-2E and F). While few cells were coinfected or infected
with either MN/99 or NC/02 viruses, more than half of the cells analyzed were infected
with TX/96 with 67.1% infected with TX/96 when MN/99 was delayed and 59.6%
infected with TX/96 when NC/02 was delayed (Figure 2-2E and F). Despite a 48 hour
incubation, no conditions resulted in 100% infection rate (Figure 2-3).
When the MOI was increased to 1, very similar results were observed for the
delayed infections but a smaller difference was observed during the simultaneous
infection. Simultaneous infections with TX/96 and either MN/99 or NC/02 lead to very
few cells only infected with TX/96, 0.8% vs. 0.2%, respectively (Figure 2-4A and B). At
the higher MOI, there were about 1.6 times more coinfected cells when NC/02 and TX/96
were used (37.2%) compared to when MN/99 and TX/96 were used (22.9%)
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Figure 2-2: Flow cytometry dot plots at an MOI of 0.01
A) MDCK cells simultaneously infected with MN and TX. B) MDCK cells simultaneously infected with NC and TX. C-D) Cells
infected with TX and either MN or NC added 24 hpi. E-F) MDCK cells infected with TX and either MN or NC added 24 hpi.
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Figure 2-3: Percentage of cells infected with either H1, H3, or coinfected with a
starting MOI of 0.01
Purple represents the percentage of negative cells. Green bars represent H1 infected while
blue represent H3 infected cells. Red corresponds with coinfected cells. The largest
percent of coinfected cells occur only during simultaneous H1N1 and H3N2 infection.
When either H1N1 or H3N2 virus addition was delayed by 24 hours, there is very few to
no coinfected cells detected.
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Figure 2-4: Flow cytometry dot plots at an MOI of 1
A) MDCK cells simultaneously infected with MN and TX. B) MDCK cells simultaneously infected with NC and TX. C-D) Cells
infected with TX and either MN or NC added 24 hpi. E-F) MDCK cells infected with TX and either MN or NC added 24 hpi.
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(Figure 2-4A and B and Figure 2-5). Additionally, when TX/96 infection was delayed
24 hours, very few cells became infected with the H3 virus with only a slight increase of
coinfected cells at 0.3% for MN/99 and TX/96 and 0.7% for NC/02 and TX/96 (Figure
2-4C and D). Again, when the H1 viruses were delayed by 24 hours, very few cells were
coinfected with only 1.7% for MN/99 and TX/96 while only 1.1% for NC/02 and TX/96
(Figure 2-4E and F). Even at the MOI of 1 and 48 hour incubation, not all of the cells
were infected (Figure 2-5).
Growth Differences in MDCK Cells
At, a simultaneous infection with an MOI of 0.01 there seemed to be more H3
virus exclusion observed between MN/99 and TX/96 when compared to NC/02 and
TX/96 which was not seen at an MOI of 1. However, there were still numerous
superinfected cells between MN/99 and the TX/96 virus providing opportunities for
reassortment. Any reassortant viruses need to have sufficient growth properties to
become successful, so, growth kinetic experiments were completed to determine if
MN/TX viruses lack the fitness required to outcompete MN/99 compared to NC/02 and
NC/TX viruses. Initial growth kinetic experiments indicate that MN/99 is significantly
slower at establishing an infection when compared to NC/02, NC/TX, and TX/96 at 10
and 12 hpi (Figure 2-6). NC/02 did have increased titers over NC/TX at 10 hpi (P<0.01).
Interestingly, MN/TX grew to higher titers than MN/99 at 12 hpi (P<0.05). Despite the
early differences observed, all viruses were at similar titers by 24 hpi and remained
similar through 72 hpi.
Discussion
Simultaneous Coinfection Provides the Greatest Possibility for Superinfection
In order for reassortment to occur, two distinct viruses must be able to superinfect
the same cell. When the second virus is delayed by at least 24 hours, it is evident that the
initial infecting virus is able to exclude the second virus from superinfection. This could
be the result of various mechanisms. However, the data here suggests that either the
second virus is not able to enter the cell or translation of the second viral proteins is
inhibited. This is evidenced by the fact that no H1 is present on the cell surface when the
H1 virus is delayed 24 hours and similarly no H3 is present when the H3 virus is delayed
by 24 hours. Therefore, the infections must occur relatively close together, at least in
vitro. There would likely be an increased time frame for 2 different viruses to infect a
single host and still produce reassortants because the respiratory tract of either a human
or pig will contain significantly more cells than can be modeled in a cell culture dish. For
example, it can be expected that although full exclusion is seen after 24 hours, in a
respiratory tract it is unlikely that a second virus would be fully excluded due to the large
number of uninfected cells. Despite these restrictions, the only difference observed
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Figure 2-5: Percentage of cells infected with either H1, H3, or coinfected with a
starting MOI of 1
Purple represents the percentage of negative cells. Green bars represent H1 infected while
blue represent H3 infected cells. Red corresponds with coinfected cells. The largest
percent of coinfected cells occur only during simultaneous H1N1 and H3N2 infection.
When either H1N1 or H3N2 virus addition was delayed by 24 hours, there was very few
to no coinfected cells detected.
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Figure 2-6: Viral growth kinetics on MDCK cells at an MOI of 0.01
MN/99 grows at a significantly slower rate compared to NC/02 and TX/96 at 10 and 12
hpi (P<0.001) and at 10 hpi MN/99 titer is significantly lower than NC/TX (P<0.05).
MN/TX grew to a significantly higher titer at 12 hpi compared to MN/99 (P<0.05).
NC/02 grew to significantly higher titers compared to NC/TX only at 10 hpi (P<0.01).
The asterisks denote time points with significant differences observed with the color
matching the parental strain of the comparison.
***
P<0.001
*
P<0.05
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between the number of coinfected cells of MN/99 with TX/96 and NC/02 with TX/96
occurred at the lower MOI of 0.01 during the simultaneous infection. In both MOI
conditions there were more coinfected cells when NC/02 and TX/96 than MN/99 and
TX/96, but this difference could be explained by the difference in growth kinetics of
NC/02 and MN/99 rather than exclusion, because MN/99 has shown a kinetic delay in its
ability to establish an infection. Thus, there would be an overall lower percentage of cells
infected with MN/99 which reduces the possibility for superinfected cells. Additionally,
the lower percentage observed between MN/99 and TX/96 still provides a large number
of superinfected cells capable of producing reassortant viruses. So, the biological
significance of the reduced superinfection percentage is difficult to determine.
Interestingly, in both MOI conditions, there are a relatively large number of cells
not infected in some instances with most percentages above 30%. It is expected that after
48 hour incubations, all of the cells would be infected especially with an MOI of 1. There
are several possible explanations for this phenomenon. After infection, the cells enter an
antiviral state in which IFN-α/β are produced as well as increased expression of RNase L
and other antiviral proteins. This antiviral state has been known to reduce viral protein
expression and the ability of viruses to infect cells. However, some cell types, including
MDCK have relatively weak IFN expression profiles. Another possible explanation for
the uninfected cells would be the production of defective interfering particles (DI). DI
particles spontaneously arise during viral replication and are usually the result of a
genetic deletion in one of the segments which results in a noninfectious virus. The
segment containing the deletion can be preferentially replicated at a higher frequency due
to its shorter length and can also be encapsidated in budding virions reducing the
production of viable virions. These DI particles can also bind to naïve cells and induce an
antiviral state which may be responsible for preventing viral replication in the uninfected
cells.
Both MN/99 and NC/02 Are Compatible with Human H3 and N2
Although there is reduced opportunity for MN/99 to reassort compared to NC/02,
the fact that 8-22% percent of cells are coinfected indicates that there is another
mechanism that has prevented MN/99 reassortment. Not only do the cells need to be
superinfected, but any progeny reassortant viruses need to have adequate fitness to
compete with the parental strains. To test if the swine virus backbones are compatible
with the human H3 and N2 genes and if the reassortant viruses have sufficient fitness to
compete with the parental strains, growth kinetics were performed on MDCK cells. The
MN/99 showed a significant disadvantage compared to the other viruses at the early time
points but was able to recover by 24 hpi. This pattern was mirrored by the MN/TX virus,
but the reassortant virus grew slightly faster than the wholly classical swine virus. This
clearly demonstrates that the classical swine gene segments are compatible with the
human surface viral glycoproteins. It should be noted that even though the human HA
and NA are compatible on both swine virus backbones, the TRIG virus has a clear growth
advantage over the classical swine virus in the context of a cell model system. This
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doesn’t help to establish why MN/99 didn’t reassort, but it does help to explain why the
TRIG viruses have displaced the classical swine viruses today.
Interestingly, the wt TX/96 outgrew all of the tested viruses. Previous studies
have shown a fitness disadvantage for TX/96 in the swine model suggesting that MDCK
cells may not be the most accurate model for testing fitness and reassortment studies of
swine viruses. These results should therefore be confirmed in additional models.
Conclusions
Based on the MDCK model, the classical swine viruses are capable of reassorting
with the human viruses and obtaining the human HA and NA similar to what had been
seen with the swine viruses containing the TRIG. The cells infected with the classical
swine virus do show a decreased percentage of superinfection, however, the biological
relevance is difficult to determine. Due to fewer superinfected cells, there is a reduced
possibility for reassortment to occur with the classical swine viruses, regardless, there are
still numerous opportunities for reassortment.
Additionally, the MN/TX virus showed increased growth kinetics compared to
MN at early time points suggesting that the reassortant phenotype would be able to
outcompete the parental strain. The triple reassortant swine virus also showed increased
growth fitness compared to the classical swine viruses which helps to explain ultimately
why they have become the predominant swine virus.
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CHAPTER 3.

INFLUENZA VIRUS GENE COMPATIBILITY AND
MECHANISMS OF REASSORTMENT
Introduction

Swine viruses with the TRIG cassette were able to displace the previously
circulating classical swine viruses because they are more fit than the classical swine virus
MN/99 and the reassortant classical swine virus MN/TX, as determined by growth
kinetics studies in vitro described in Chapter 2. Interestingly, the human H3N2 virus,
TX/96, grew extremely well in the MDCK cells, which is contrary to what has been seen
in in vivo pig experiments previously.66 This indicates that the results need to be
confirmed in an alternate model that mirrors epidemiological data. To confirm the
Chapter 2 results, primary swine respiratory epithelial cells (pSRECs) were cultured to
better model in vivo growth kinetics.71
The segmented nature of the influenza genome provides opportunities for
reassortment to occur because individual segments can be packaged within virions of a
different influenza virus. Recent studies have shown that reassortant viruses are generated
quite readily in vitro.72-74 Although the segmented genome increases the possibility for
the emergence of numerous reassortant viruses, there are multiple mechanisms which
restrict this ability, many of which have not been thoroughly investigated. This was
clearly demonstrated in vivo where swine were coinfected with a classical swine H1N1
and a TRIG H3N2 swine virus. Multiple reassortants were detected in the infected
animals but only certain viruses were capable of transmission.65 One mechanism of
restriction is that the HA and NA proteins need to be balanced. If the HA binds too
tightly compared to NA activity, then the budding virions will not efficiently release.
These virions will also have an increased tendency to aggregate. Conversely, if the NA is
relatively more active, then the HA may not have enough binding affinity to bind to the
cell long enough to be endocytosed, precluding infection.75,76 As mentioned previously,
HA fusion is a pH dependent process; similarly, M1 oligomerization and disassembly are
dependent on the pH.77,78 There is no direct evidence, but presumably the HA and M need
to be pH balanced so that the HA does not fuse the membranes prior to the proper
acidification of the virion core and disassembly of the matrix capsid and vice versa.
Additionally, the interactions of the polymerase proteins require that they are compatible
with each other, capable of recognizing the RNP’s of the particular viral genotype, as
well as the ability to function within particular cell types.7,79,80
Clearly, reassortment is limited by multiple polygenic mechanisms. To compare
the reassortment abilities of the classical swine viruses versus triple reassortant swine
viruses with a human H3N2 virus, primary swine respiratory epithelial cells (pSRECs)
were coinfected with A/TX/6/1996 (TX/96) a human H3N2 and either
A/swine/MN/37866/1999 (MN/99) a classical swine H1N1 virus, or
A/swine/NC/18161/2002 (NC/02) a triple reassortant swine virus that contains the TRIG
cassette. To test the natural ability of these viruses to reassort, swine respiratory cells
were coinfected with TX/96 and MN/99 or NC/02.
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To expand upon previous reassortment experiments in which only the presence of
classical swine or triple reassortant swine PB2 or PA genes with human H3N2
glycoproteins,66 the following experiments look at reassortment potential of all 8 gene
segments through the use of deep sequencing. These experiments also explore the growth
effects of polymerase complex reassortment by using reverse genetics to rescue viruses
with differing polymerase gene compositions.
Materials and Methods
Reverse Genetics Viruses
For the following experiments multiple reverse genetics viruses were rescued
based around the RG-MN/99 classical swine H1N1 virus, the RG-NC/02 triple
reassortant H1N1 virus, and TX/96 human H3N2 virus. The RG viruses were generated
using the dual promoter eight plasmid system as outlined in Figure 2-1 and Chapter 2.70
The rescued virus supernatants are then injected into 10 day old embryonated chicken
eggs and incubated at 35°C for 48 hours. The allantoic fluid was harvested and reinjected into embryonated chicken eggs for a second passage. The virus was harvested,
aliquoted, and stored at -80°C. Each vial was only thawed once before use in each
experiment. All of the genotypes used for the growth kinetics experiments are identified
in Table 3-1.
Primary Swine Respiratory Epithelial Cells (pSRECs)
Due to previous experiments showing MDCK growth kinetics studies differing
from in vivo observations, it was determined a new model needed to be utilized to more
accurately model swine. Isolation and growth of the primary swine respiratory epithelial
cells was adapted from methods developed in the lab of Chris Olsen and outlined in
Appendix B.71,81 Briefly, pig tracheas were collected courtesy of David Keith at the
Fayette Packing Company in Eads, TN. The epithelial cells were enzymatically digested
from the trachea with a Pronase/DNase mixture (56 mg Pronase (Roche catalog number
165921), 4 mg DNase (sigma catalog number DN-25)).Adherent fibroblasts were
removed by incubating the cell suspension on uncoated tissue culture treated petri dishes
(BD Biosciences, Falcon, catalog number 353003). The epithelial cells were collected
and centrifuged at 1200 RPM for 10 min at 4°C and then resuspended in 100 ml of
DMEM/F12 media (Invitrogen catalog number 11320-033) prior to counting on a
Countess cell counter (Invitrogen catalog number C10227). After counting the cells were
centrifuged again at 1200 RPM for 10 min at 4°C and resuspended in BEGM (Lonza
catalog number CC-3170) supplemented with 20% FCS to 4x106 cells/ml. On ice, a
solution of BEGM, 20% FCS and 20% DMSO was added dropwise to the cell suspension
until the final cell concentration was 2x106 cells/ml. The cell suspension was aliquoted in
1 ml volumes and stored in the gas phase of a liquid nitrogen storage tank.
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Table 3-1:

Gene segment origins for rescued viruses
Gene segment source

RG-virus
abbreviation

PB2

PB1

PA

HA

NP

NA

M

NS

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

NC/02

MN/99

MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99

TX/96*

Wild Type

NC/TX

NC/02

NC/02

TX/96

NC/02

TX/96

NC/02

MN/TX

MN/99 MN/99 MN/99

TX/96

MN/99

TX/96

MN/99 MN/99

MN/99 NC/02 MN/99

TX/96

MN/99

TX/96

MN/99 MN/99

NC/02

MN/99 MN/99

TX/96

MN/99

TX/96

MN/99 MN/99

MN/99 MN/99 NC/02

TX/96

MN/99

TX/96

MN/99 MN/99

NC/02

MN/99 NC/02

TX/96

MN/99

TX/96

MN/99 MN/99

NC/02

NC/02

NC/02

TX/96

MN/99

TX/96

MN/99 MN/99

MN/99 MN/99 MN/99

TX/96

MN/99

TX/96

MN/99

NC/02

NC/02

TX/96

NC/02

TX/96

NC/02

NC/02

MN/TX/NCPB1
MN/TX/NCPB2
MN/TX/NCPA
MN/TX/NCPB2 PA
MN/TX/NCPol
MN/TX/NCNS
NC/TX/MNPB1

NC/02

MN/99 NC/02

NC/02

The orange boxes indicate gene segments from the TRIG swine virus NC/02. The blue
boxes indicate gene segments of classical swine lineage from MN/99 and the green boxes
are genes derived from the human H3N2 virus, TX/96.
* TX/96 is a wild type virus and only HA and NA were cloned for rescue on the swine
viral backbones.
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Prior to pSREC propagation, tissue culture flasks or plates were coated with 5%
(w/v) type VI human placental collagen (Sigma catalog number C7521) dissolved in
ddH2O with 0.2% (v/v) glacial acetic acid and incubated at room temperature overnight.
Prior to use, the collagen coating solution was aspirated and the flasks or plates were
allowed to fully dry in a biosafety cabinet.
Cell vials were removed from liquid nitrogen storage and thawed in a 37°C water
bath and the cell suspension was transferred to a 15 ml tube to be slowly resuspended.
Once fully resuspended in 10 ml of DMEM/F12 or BEGM, the cells were added to a 75
cm2 tissue culture flask with 15 ml of BEGM and incubated at 37°C with 5% CO2
overnight. Half of the media was replaced 1 or 2 days after seeding and the cells were
typically 80-90% confluent 2-4 days later.
Coinfections
To show whether MN/99 and NC/02 are able to reassort with TX/96 at different
frequencies, pSRECs were coinfected and progeny viruses were genotyped. Six-well
tissue culture plates were prepared with pSRECs and incubated until they were 80-90%
confluent. Once nearly confluent, cells were counted to calculate MOIs. The pSRECs
were simultaneously infected with TX/96 and either NC/02 or MN/99 each at an MOI of
0.01. The viral dilution was incubated on the cells at 37°C at 5% CO2 for 1 hour and then
the cells were washed with PBS. Fresh BEGM, supplemented with 0.5 µg/ml TPCKTrypsin, was added and the infected pSRECs were incubated for 48 hours. After 48 hours
the supernatants were collected and stored at -80°C until plaque purification.
For plaque purification, three 6-well tissue culture plates per coinfection were
prepared with MDCK cells in order to pick 96 plaques. For each coinfection, the virus
was diluted 1 to 1x10-4 in 8 ml of infection media and serially diluted to 1x10-6. To
ensure only H3 viruses were selected for sequencing, 80 µl of an anti-H1 antibody
(selected from the St. Jude repository and created against NC/02) was added to each
dilution for a 1:100 dilution. Each dilution was incubated on ice for 1 hour prior to viral
absorption. The cells were then washed with 1X PBS and 1 ml of the viral dilution was
added to each well. The plates were incubated at 37°C with 5% CO2 for 1 hour. The virus
dilution was then aspirated and the MDCK monolayers were washed with 1X PBS and
the cells were overlaid with 1X infection media mixed with 0.9% bacto agar (BD
Biosciences catalog number 214010) and supplemented with 0.5 µg/ml TPCK-Trypsin
and incubated at 37°C with 5% CO2 for 48 hours. Identifiable isolated plaques were
aspirated using a wide bore pipet tip (Fisherbrand catalog number 02-707-74). The viral
plug was then ejected into one well of an 96-well tissue culture plate about 80%
confluent with MDCK cells and each plate was incubated for an additional 72 hours. To
confirm viral growth, a hemagglutination assay was performed by adding 25 µl of 1X
PBS to a 96-well round-bottom plate followed by 25 µl of the viral supernatant and
finally 50 µl of 0.5% (v/v) turkey red blood cells. The plate was then gently tapped to
mix and incubated at room temperature for about 30 min. After the incubation, the plates
were read for red blood cell agglutination.
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Identification of Reassortants
To identify and quantify the reassortant viruses, the Illumina MiSeq platform was
utilized for multiplex full genome sequencing of 96 samples in a single run. The viral
RNA was extracted using the Ambion MagMAX-96 AI ND Viral RNA Isolation Kit
(catalog number AM1835). The MagMAX kit is a magnetic bead based system in which
the virus was lysed and the RNA was bound on magnetic beads. The beads were washed
to purify the sample of contaminating protein and DNA. Finally, the RNA was eluted off
of the magnetic beads. The purified viral RNA was reverse transcribed using SuperScript
III reverse transcriptase (Invitrogen catalog number 18080044) and the cDNA was
amplified using Phusion High-Fidelity PCR Master Mix (New England BioLabs catalog
number M0531L) combined with the primers in Table 3-2 and using the thermocycler
conditions outlined in Table 3-3. The amplified samples were then fragmented to 400500 base pairs using the Covaris E220 Focused-ultrasonicator with samples in AFA
microtubes (Covaris catalog number 520078) at a 10% duty cycle, intensity of 5, 200
cycles per burst, for a total of 70 seconds at 4°C. After shearing, the samples were
processed following the Bioo Scientific NEXTflex DNA sequencing kit (Bioo Scientific
catalog number 5140-02). This procedure added unique adapters to each sample. The
samples then underwent size selection, PCR enrichment, and a final magnetic bead clean
up. The samples were then submitted to the St. Jude Hartwell Center and sequenced on
the Illumina MiSeq system. The subsequent sequencing data was analyzed using the CLC
Genomics Workbench version 6 program.
Growth Kinetics
The RG viruses and wt TX/96, as outlined in Table 3-1, were used to infect
MDCK cell monolayers at an 80-90% confluency or pSRECs at an MOI of 0.01. MOIs
were calculated by counting trypsinized cells using the Countess (Invitrogen catalog
number C10227). The viruses were diluted in infection media to an MOI of 0.01 and
added to the cells. After about an hour the cells were gently washed with 1X PBS and
infection media with 0.5% TPCK-Trypsin was added. For the MDCK growth kinetic
experiments, 2 x 100 µl samples were collected at the following time points, 6, 8, 10, 12,
20, 24, 36, and 48 hpi. All of the samples collected were stored at -80°C until viral
TCID50 titers could be determined. For the pSREC infections, 2 x 100 µl samples were
collected at 10, 12, 14, 16, 18, 20, 24, 36, and 48 hpi. These viral samples were also
stored at -80°C until TCID50 titers could be determined. No samples were thawed prior to
titration. All TCID50 titers were determined using MDCK cells in a 96 well flat bottom
tissue culture plate at 80-90% confluency. Significance was calculated using a 2way
ANOVA analysis.
Pig Infections and Transmission
Twenty-two two-week-old influenza negative pigs were received from
Northwoods Pork (Parker Prairie, MN). The pigs were divided into four groups of 5 pigs
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Table 3-2:

Primer sequences used for influenza genome amplification

Primer name
Uni 12
Uni 13
Ba-PB2-1
Ba-PB2-2341R
Bm-PB1-1
Bm-PB1-2341R
Bm-PA-1
Bm-PA-2233R

Table 3-3:

Primer sequence
AGCAAAAGCAGG
AGTAGAAACAAGG
TATTGGTCTCAGGGAGCGAAAGCAGGTC
ATATGGTCTCGTATTAGTAGAAACAAGGTCGTTT
TATTCGTCTCAGGGAGCGAAAGCAGGCA
ATATCGTCTCGTATTAGTAGAAACAAGGCATTT
TATTCGTCTCAGGGAGCGAAAGCAGGTAC
ATATCGTCTCGTATTAGTAGAAACAAGGTACTT

Thermocycler conditions for full influenza genome amplification
Temperature
98°C
98°C
45°C
72°C

Time
30 sec
10 sec
30 sec
90 sec

98°C
58°C
72°C
72°C
4°C

10 sec
30 sec
90 sec
10 min
Hold
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Cycling repeats
10

20

and one group of 2 pigs under BSL-2 conditions and each group was housed in straw
lined pens in individual cubicles with no contact with any other group. All pigs had
access to food and water ad libitum and social enrichment items were included in each
pen.
The viruses, RG-MN/TX, RG-NC/TX, TX/96, RG-MN/TX/NC-PB1, were
diluted to 1x106 plaque forming units (PFU)/ml in 15 ml of 1X PBS and 1X egg
antibiotic (2000 units/ml penicillin, 400 units/ml streptomycin, 200 units/ml Polymyxin
B, 50 µg/ml gentamicin). Two pigs from each group were infected intranasally with 12x106 PFU of one of the listed viruses using a metered pump nasal spray bottle (Health
Care Logistics catalog number 10271). PBS with egg antibiotic was used for the control
pigs. The pigs were restrained and 2 pumps of the viral dilution were administered to
each nostril for a total administration of about 2 ml. Each pig was monitored daily for any
clinical signs of disease.
Starting 1 day post infection (dpi) and every-other day until 15 dpi, all pigs were
swabbed in each nostril and the swabs were placed in 500 µl isolation media aliquots
(Table 3-4) and held on ice until they could be stored at -80°C. The swabs were then
titrated on MDCK cells to calculate TCID50 values as described for growth kinetics.
Results
Reassortment Frequency
To test the inherent ability of MN/99 and NC/02 to reassort with TX/96, the
pSRECs were coinfected at an MOI of 0.01 and the progeny were fully genotyped to
identify and quantify the number of reassortant viruses created. A surprisingly large
variety of reassortant viruses were recovered from the pSREC coinfections between
MN/99 and TX/96 (Table 3-5). The most prevalent virus recovered was the wt TX/96
virus at 14% of the 93 genotyped viruses. Nearly 80% of the viruses had acquired the
human H3 segment. The MN/99 NP gene segment appeared to reassort the most
frequently and was identified in about 74% of the viruses followed by NS at 63% and M
Table 3-4:

Viral isolation media composition

Reagent
PBS
Glycerol

Volume for 100 ml
45 ml
50 ml

100X Pen-Strep

1 ml

Nystatin
Polymyxin B
Gentamicin

1 ml
2 ml
0.5 ml
33

Final concentration
50%
Penicillin (1000 u/ml);
streptomycin (200 µg/ml
50 u/ml
100 u/ml
200 µg/ml

Table 3-5:
Reassortment frequency between MN/99 and TX/96 when coinfected
in pSRECs at an MOI of 0.01
PB2

PB1

PA

HA

NP

NA

M

NS

TX
TX
TX
TX
TX
MN
MN
MN
TX
TX
TX
TX
TX
TX
TX
TX
MN
MN
MN
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX

TX
TX
TX
TX
TX
TX
TX
TX
MN
TX
TX
TX
TX
TX
TX
TX
MN
MN
TX
MN
MN
MN
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX

TX
MN
TX
TX
TX
MN
MN
TX
MN
MN
MN
MN
MN
TX
TX
TX
MN
MN
MN
MN
MN
TX
MN
MN
MN
MN
MN
MN
MN
TX
TX
TX
TX
TX
TX
TX

TX
TX
TX
TX
TX
TX
MN
TX
TX
MN
TX
TX
TX
MN
TX
TX
MN
MN
MN
MN
MN
TX
MN
MN
MN
TX
TX
TX
TX
MN
MN
MN
TX
TX
TX
TX

TX
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
TX
MN
MN
TX
MN
MN
TX
MN
MN
MN
MN
MN
MN
MN
TX
TX
TX
MN
MN
TX
MN
MN
MN
TX

TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
MN
TX
TX
TX
MN
MN
MN
TX
TX
MN
TX
TX
MN
MN
TX
TX
MN
TX
TX
MN
MN
MN
MN
MN
TX
TX

TX
MN
TX
MN
TX
MN
MN
MN
MN
MN
MN
TX
TX
TX
MN
TX
MN
MN
MN
TX
MN
MN
MN
TX
TX
MN
MN
MN
TX
MN
TX
MN
MN
TX
MN
TX

TX
MN
TX
MN
MN
MN
MN
MN
MN
MN
MN
TX
TX
MN
MN
TX
MN
MN
MN
MN
MN
MN
MN
MN
TX
TX
MN
TX
MN
MN
TX
MN
TX
MN
TX
MN
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Number
identified
13
10
7
6
6
4
3
3
3
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

% of
sample
14.0%
10.8%
7.5%
6.5%
6.5%
4.3%
3.2%
3.2%
3.2%
3.2%
3.2%
3.2%
3.2%
2.2%
2.2%
2.2%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%

Table 3-5:

(Continued)

The blue boxes indicate gene segments of classical swine lineage and the green boxes are
genes derived from the human H3N2 virus, TX/96.
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at 54%. Additionally, of the 74 viruses that were identified as H3, 63 (85%) also
contained the TX/96 PB2 and PB1 gene segments. Only 9.5% of the 74 H3 viruses had
the MN/99 PB2 gene and only 5.5% had the MN/99 PB1 gene segment.
Based on correlation analysis of the genotypes identified between MN/99 and
TX/96, four gene segments were shown to share more than 15% of the variance in
common (Table 3-6). The M and NP correlated in 19.3% of the genotypes while M and
PA shared 20% of the variance. The NS segment correlated with both the NP at 27.2%
and the M segment at 40.9%.
There was less viral diversity identified in the genotyped viruses collected from
the NC/02 and TX/96 coinfections. (Table 3-7). There were only 21 different genotypes
identified compared to the 36 genotypes between MN/99 and TX/96. The most dominant
genotype identified was the human H3 with the remaining 7 gene segments from NC/02
(34.4%). The second most prevalent genotype was very similar, with both the H3 and
TX/96 PB2 gene segment and the other 6 segments were from NC/02 (15.6%). Of the 96
samples genotyped, 88.5% of them were H3 positive. Only 27 (31.8%) of the 85 H3
viruses contained the human derived PB1 segment while 58 (68.2%) contained the NC/02
PB1 segment. The most interesting aspect of these reassortants was that 81 of the 85
(95.3%) H3 viruses contain at least one polymerase segment from the NC/02 virus. Of
the 85 H3 viruses 44.7% had all polymerase segments from NC/02. While 21.1% had
both PB1 and PA from NC/02, only 8.2% had NC/02 PB2 and PA gene segments. Only 1
virus (1.2%) had both PB2 and PB1 from NC/02. There are considerably more NC/02
polymerase gene segments reassorted with the human H3 than what was observed
between MN/99 and TX/96 where only 34 of the 74 (45.9%) H3 viruses contain at least
one MN/99 segment, most of which is the PA gene segment 23 of 34 (67.6%).
Table 3-6:
Gene
segment
PB2
PB1
PA
HA
NP
NA
M
NS

Correlation analysis of MN and TX reassortant genotypes
PB2
0.010
0.057
0.066
0.028
0.012
0.140
0.094

PB1

PA

HA

NP

NA

M

NS

0.098

0.239
0.247

0.257
0.225
0.268

0.167
0.181
0.214
0.177

-0.110
0.053
-0.002
0.243
0.025

0.374
0.208
0.447
0.149
0.439
0.104

0.306
0.233
0.317
0.274
0.522
0.128
0.639

0.061
0.051
0.033
0.003
0.043
0.054

0.072
0.046
0.000
0.200
0.100

0.031
0.059
0.022
0.075

0.001
0.193
0.272

0.011
0.016

0.409

The top half of the table shows the correlation r values and the bottom half are the r2
values which are the coefficient of determination values and represent the fraction of
variance shared between the gene segments.
Highlighted values show 15% or more correlation between the gene segments.
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Table 3-7:
Reassortment frequency between NC/02 and TX/96 when coinfected
in pSRECs at an MOI of 0.01
PB2

PB1

PA

HA

NP

NA

M

NS

NC
TX
NC
NC
TX
NC
TX
TX
TX
TX
TX
NC
NC
NC
NC
NC
NC
TX
TX
TX
TX

NC
NC
NC
TX
TX
NC
TX
TX
NC
TX
TX
NC
NC
TX
TX
TX
TX
NC
NC
TX
TX

NC
NC
NC
NC
NC
NC
TX
NC
NC
TX
TX
NC
TX
NC
NC
TX
NC
NC
TX
NC
NC

TX
TX
NC
TX
TX
TX
TX
TX
TX
TX
TX
TX
TX
NC
TX
TX
TX
TX
TX
NC
TX

NC
NC
NC
NC
NC
NC
TX
NC
NC
NC
NC
NC
NC
NC
NC
NC
NC
NC
TX
NC
NC

NC
NC
NC
NC
NC
TX
TX
TX
TX
NC
NC
NC
NC
NC
TX
TX
TX
TX
TX
NC
NC

NC
NC
NC
NC
NC
NC
TX
NC
NC
NC
TX
NC
NC
NC
NC
TX
NC
NC
TX
NC
NC

NC
NC
NC
NC
NC
NC
TX
NC
NC
NC
NC
TX
NC
NC
NC
NC
NC
TX
NC
NC
TX

Number
identified
33
15
9
7
5
4
4
3
2
2
2
1
1
1
1
1
1
1
1
1
1

% of
sample
34.4%
15.6%
9.4%
7.3%
5.2%
4.2%
4.2%
3.1%
2.1%
2.1%
2.1%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%

The orange boxes indicate gene segments of the TRIG swine lineage and the green boxes
are genes derived from the human H3N2 virus, TX/96.
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The genotypes identified between NC/02 and TX/96 showed an increased number
of correlated gene segments when compared to MN/99 and TX/96. The PA segment
correlated with numerous segments including PB1 (16.3%), NP (42.5%), M (70.2%), and
NS (16.2%) (Table 3-8). The NP segment also showed significant correlation with the
NA (23.8%), M (60.4%), and NS (43.0%) segments. The NA and M segments also
shared 18.9% of the variation while M and NS were correlated in 24.5% of the viruses.
MDCK Cell Growth Differences
Growth kinetics of particular viral reassortants were tested to identify if they have
sufficient growth fitness to compete with the parental strains. As seen in Figure 3-1, the
parental viral strains show very similar growth kinetics to the 6+2 viruses where the
human H3 and N2 are added on either the classical swine or the triple reassortant
backbones. The different viral surface glycoproteins showed no effect on the viral growth
kinetics. Compared to MN/99, NC/02 grew to higher titers at 10 and 12 hpi (p<0.001)
and 20 and 24 hpi (p<0.01), while NC/TX grew to higher titers than MN/TX at 10 and 20
hpi (p<0.001). Similarly, TX/96 grew to significantly higher titers than MN/TX at 10 and
12 hpi (p<0.001) and 20 hpi (p<0.01).
When the gene segments of the polymerase complex in both the classical swine
virus and TRIG virus are reassorted in the context of the human H3 and N2, there are
some identifiable growth differences observed (Figures 3-2 and 3-3). The reverse
genetics MN/TX virus grew at significantly lower titers compared to TX/96 at 10, 12, and
20 hpi (P<0.001). Additionally, none of the reverse genetics viruses containing any of the
NC/02 polymerase segments showed increased growth kinetics compared to MN/TX.
Table 3-8:
Gene
segment
PB2
PB1
PA
HA
NP
NA
M
NS

Correlation analysis of NC and TX reassortant genotypes
PB2
0.101
0.102
0.047
0.088
0.050
0.092
0.074

PB1

PA

HA

NP

NA

M

NS

0.318

0.320
0.404

0.218
0.094
0.129

0.296
0.254
0.652
0.084

0.223
0.265
0.330
0.173
0.488

0.303
0.376
0.838
0.108
0.777
0.435

0.272
0.252
0.402
0.101
0.656
0.379
0.495

0.163
0.009
0.065
0.070
0.142
0.063

0.017
0.425
0.109
0.702
0.162

0.007
0.030
0.012
0.010

0.238
0.604
0.430

0.189
0.143

0.245

The top half of the table shows the correlation r values and the bottom half are the r2
values which are the coefficient of determination values and represent the fraction of
variance shared between the gene segments.
Highlighted values show 15% or more correlation between the gene segments.
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Figure 3-1: MDCK growth kinetics of parental and 6+2 viruses at an MOI = 0.01
There were no significant differences observed between MN/99 and MN/TX or between
NC/02 and NC/TX. MN/99 does show significantly lower titers than both NC/02 and
TX/96 at 10 and 12 hpi (P<0.001) and just NC/02 at 20 and 24 hpi (P<0.01). MN/99 also
has significantly lower viral titers at 12 and 20 hpi when compared to NC/TX (P<0.05
and P<0.01 respectively). The asterisks denote time points with significant differences
observed with the color matching the parental strain of the comparison.
***
P<0.001
**
P<0.01
*
P<0.05

39

Figure 3-2: Growth kinetics of RG viruses in MDCK cells where the polymerase
gene segments have been swapped on the MN/TX viral backbone
MN/TX grows at a significantly slower rate compared to TX/96 at 10, 12, and 20 hpi
(P<0.001). When comparing all of the polymerase reassortants to MN/TX, none show
increased growth kinetics in MDCK cells. Addition of the NC-PB1 resulted in
significantly lower titers at 12 hpi (P<0.05) and 24 hpi (P<0.001). The NC-PB2 causes a
slight growth reduction at 12 phi (P<0.05) while NC-PA causes reduced viral titers at 12
(P<0.05), 24, 36 (P<0.001), and 48 (P<0.01) hpi. When both NC-PB2 and PA are
included they have a cumulative effect and significantly inhibit attenuate viral growth
compared to MN/TX at 12 and 20 hpi (P<0.05) and 24-48 (P<0.001) hpi. The asterisks
denote time points with significant differences observed with the color matching the
parental strain of the comparison.
***
P<0.001
**
P<0.01
*
P<0.05
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Figure 3-3: Growth kinetics of RG viruses in MDCK cells where MN-PB1 was
swapped on the NC/TX viral backbone
NC/TX showed no significant growth difference compared to TX/96. Addition of the
MN-PB1 did attenuate the virus compared to NC/TX at 10, 12, 20, 24, and 48 (P<0.001)
hpi. Inclusion of the NC PB2 and PA in the MN/TX/NC-PB2 PA virus did not rescue the
higher growth kinetics seen in the NC/TX virus and was attenuated in all time points
tested (10-48 hpi P<0.001). The asterisks denote time points with significant differences
observed with the color matching the parental strain of the comparison.
***
P<0.001
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MN/TX/NC-PB1 grew to significantly lower titers at 12 (P<0.05) and 24 hpi (P<0.001).
The NC-PB2 rescued in the MN/TX virus, causes a slight growth attenuation at 12 hpi
(P<0.05) while the NC-PA causes reduced viral titers at 12 (P<0.05), 24, 36 (P<0.001),
and 48 (P<0.01) hpi. When both the PB2 and PA are included in MN/TX/NC-PB2 PA,
they have a cumulative effect and significantly inhibit attenuate viral growth compared to
MN/TX at 12 and 20 hpi (P<0.05) and 24-48 (P<0.001) hpi (Figure 3-2).
NC/TX showed no significant growth difference compared to TX/96. Addition of
the MN-PB1 did attenuate the virus compared to NC/TX at 10, 12, 20, 24, and 48
(P<0.001) hpi. Inclusion of the NC PB2 and PA in the MN/TX/NC-PB2 PA virus was
unable to rescue the higher growth kinetics seen in the NC/TX virus and the virus was
significantly attenuated in all time points tested, 10-48 hpi (P<0.001) (Figure 3-3).
Surprisingly, when the TRIG NS was reassorted with the MN/TX, growth was
slowed at 12, 20, and 24 hpi at P<0.05, P<0.01, and P<0.001 respectively. The
MN/TX/NC NS virus had significantly lower titers than both NC/TX and TX/96 from 1024 hpi but then the titers recovered by about 36 hpi (Figure 3-4).
pSREC Growth Kinetics
Preliminary growth kinetic experiments in primary swine trachea cells showed
kinetics similar to what has previously been reported for in vivo experiments (Figure
3-5). The human H3N2 virus (TX/96) grew to lower titers when compared to the swine
viruses and the swine 6+2 viruses, as expected. This followed the pattern of lower titers
and poor transmission when swine have been experimentally infected as has been
previously reported and based on what has been seen epidemiologically.66
More extensive evaluation of the swine, human, and 6+2 viruses in the pSRECs
revealed that there is little difference in growth abilities (Figure 3-6). The only
significant difference observed was that TX/96 had a higher titer than MN/99 at 20 hpi
(P<0.05). This was opposite of what was expected due to the preliminary kinetic results.
Additionally, the pSRECs were infected with the reassorted viruses to determine
the effects that the different polymerase gene segments played on the distinct swine
backbones. The NC-PB1 in MN/TX/NC-PB1 results in significantly lower viral titers at
18 and 20 hpi (P<0.05) compared to MN/TX (Figure 3-7). During the early time points,
MN/TX/NC-PB2 grows at lower titers 14 (P<0.001) and 20 hpi (P<0.05), while the
NC/02-PA in the MN/TX/NC-PA virus causes viral growth deficiencies later at 36 hpi
(P<0.05). Addition of both the PB2 and PA have cumulative effects in MN/TX/NC-PB2
PA and attenuate the virus at 12 hpi (P<0.05), 12, 16 hpi (P<0.001), 18 hpi (P<0.05), and
20 hpi (P<0.001). However, no growth defect is observed when the whole NC
polymerase complex is exchanged for the MN polymerase trimer comparing
MN/TX/NC-Pol to MN/TX.
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Figure 3-4: MDCK growth of RG viruses with TRIG NS
MN/TX/NC NS grows at a significantly slower rate compared to wt TX/96 and NC/TX at
10-24 hpi (P<0.001). At 12 hpi MN/TX/NC NS grows at lower titers than MN/TX up
through 24 hpi (p<0.05, p<0.01, and p<0.001, respectively). The asterisks denote time
points with significant differences observed with the color matching the strain being
compared.
***
P<0.001
**
P<0.01
*
P<0.05
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Figure 3-5: Preliminary pSREC growth kinetics at an MOI of 0.01
Preliminary kinetic experiments in pSRECs mirrored other experiments where the swine
viruses grow rapidly and to higher titers compared to the human virus, TX/96. These
kinetic experiments were completed with only 1 replicate, so significance could not be
calculated.
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Figure 3-6: pSREC growth kinetics at an MOI of 0.01
There were no significant differences between any of the viruses when compared to
TX/96 except MN/99 at 20 hpi (P<0.05). The asterisks denote time points with
significant differences observed with the color matching the strain being compared.
***
P<0.001
**
P<0.01
*
P<0.05
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Figure 3-7: Growth kinetics of RG viruses in pSRECs where the polymerase gene
segments have been swapped on the MN/TX viral backbone
The MN/TX/NC-PB1 virus grew to lower titers than MN/TX at 18 and 20 hpi (P<0.05).
Compared to MN/TX, the NC/02-PB2 in MN/TX/NC-PB2 virus grows at lower titers
during the early time points of 14 hpi (P<0.001) and 20 hpi (P<0.05), while the NC/02PA in the MN/TX/NC-PA virus causes viral growth deficiencies later at 36 hpi (P<0.05).
Both the PB2 and PA have cumulative effects and attenuated the MN/TX/NC-PB2 PA
virus at 12 (P<0.05), 14, 16 (P<0.001), 18 (P<0.05), and 20 hpi (P<0.001). When the
complete NC polymerase is included in MN/TX/NC-Pol, the growth is no different than
MN/TX. The asterisks denote time points with significant differences observed with the
color matching the parental strain of the comparison.
***
P<0.001
**
P<0.01
*
P<0.05
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When the classical swine PB1 was put into the TRIG polymerase complex with
human H3N2 surface proteins, the PB1 attenuated growth of the virus at 14 (P<0.05), 20,
and 36 hpi (P<0.01) compared to NC/TX as seen in Figure 3-8. There are no growth
differences observed when the 3 TRIG polymerase segments from NC/02 are rescued
with MN/TX in MN/TX/NC-Pol compared to the NC/TX virus.
Finally, the TRIG NS had no significant effect of MN/TX/NC-NS growth in
pSRECs when compared to MN/TX (Figure 3-9). Although it had no significant
difference, the addition of the TRIG NS does seem to cause a slight reduction in its
growth especially 10-20 hpi, but the virus is able to recover around 24 hpi with an end
point titer similar to TX/96, MN/TX, and NC/TX.
Reassortant Swine Virus Infectivity and Transmissibility in Pigs
To confirm in vitro results, pigs were used to monitor infectivity and
transmissibility of a selection of reassortant swine viruses with the human viral
glycoproteins and one virus with the TRIG PB1 in the classical swine backbone. As
expected, the pigs inoculated with wt TX/96 became infected but no virus could be
detected in any of the contact animals (Figure 3-10). The viral titers peaked 1 to 3 dpi at
103.667 and 104.5 TCID50 per ml, respectively. There was also no virus detected in the
inoculated animals on day 7, so the virus had been cleared between 5 and 7 dpi.
Pigs inoculated with the TRIG PB1 reassorted with the classical swine
polymerase in the RG virus MN/TX/NC-PB1 shed detectable virus up to 7 dpi. Like the
TX/96 virus, none of the contact animals shed any virus (Figure 3-11). The virus was
slightly attenuated when compared to the other tested viruses because it was only
detected in one inoculated pig from 3-7 dpi and from 1-7 dpi in the other inoculated
animal. This virus also only reached an average peak titer of about 103.987 TCID50 per ml
5 dpi.
Interestingly, when the human HA and NA were rescued on the classical swine
virus backbone (MN/TX), the virus established a robust infection, reaching an average
peak titer of 105.282 TCID50 per ml 3 dpi (Figure 3-12). Beyond the relatively high titer
and despite the presence of the HA and NA from a human virus, MN/TX was able to
transmit to all three contact animals. Virus was first detected in the contact animals
starting 3 dpi and the highest titers were detected 5 dpi in one of the animals and 7 dpi in
the other two contact animals. However, the average peak titer was slightly lower in the
contact animals at 105 TCID50 per ml.
Similar to MN/TX, when the human HA and NA were present on the TRIG
cassette backbone (NC/TX), the virus reached relatively high titers in the inoculated
animals as well as all three of the contact animals (Figure 3-13). However, the inoculated
animals had peak titers 1 dpi with an average titer of 104.909 TCID50 per ml and the
contacts had an average peak titer of 104.41 TCID50 per ml ranging from 3-7 dpi. Although

47

Figure 3-8: Growth kinetics of RG viruses in MDCK cells where MN-PB1 was
swapped on the NC/TX viral backbone
The NC/TX/MN-PB1 virus grew to significantly lower titers at 14 (P<0.05), 20, and 36
hpi (P<0.01) compared to NC/TX. MN/TX/NC-Pol with the 3 polymerase segments from
NC/02 does not show any significant growth defects when compared to NC/TX. The
asterisks denote time points with significant differences observed with the color matching
the parental strain of the comparison.
***
P<0.001
**
P<0.01
*
P<0.05
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Figure 3-9: Reassortant viruses with TRIG NS in pSRECs
There were no significant growth differences between any of the viruses when compared
to MN/TX.
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*

Figure 3-10: Growth and transmission of human TX/96 in pigs
Virus was detected and titers were determined by TCID50. Inoculated pigs became
infected but the virus did not transmit to direct contact animals. The average peak titers
reached 104.08 TCID50 per ml.
* No virus detected from pig 149 likely the result of inadequate swab insertion.
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Figure 3-11: Growth and transmission of MN/TX/NC-PB1 in pigs
Virus was detected and titers were determined by TCID50. Inoculated pigs became
infected but the virus did not transmit to direct contact animals. The average peak titers
reached 103.99 TCID50 per ml 5 dpi.
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Figure 3-12: Growth and transmission of MN/TX in pigs
Virus was detected and titers were determined by TCID50. Inoculated pigs became
infected and the virus was capable of transmitting to all of the direct contact animals. The
average peak titers in the inoculated animals reached 105.28 TCID50 per ml 3 dpi, while
the contact animals reached an average peak titer of 105 TCID50 per ml 5-7 dpi.
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Figure 3-13: Growth and transmission of NC/TX in pigs
Virus was detected and titers were determined by TCID50. Inoculated pigs became
infected and the virus was capable of transmitting to all of the direct contact animals. The
average peak titers in the inoculated animals reached 104.91 TCID50 per ml 1 dpi, while
the contact animals reached an average peak titer of 104.41 TCID50 per ml 5 dpi.
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these titers are lower than MN/TX, the NC/TX virus was capable of reaching its peak
titer several days earlier than MN/TX.
Discussion
In Vitro Reassortment
With the high throughput sequencing capabilities of the MiSeq platform, we were
able to genotype a large number of viruses for both in vitro coinfection conditions. In
previous coinfection experiments with the classical swine virus, no reassortants were
detected.66 However, we see that MN/99 is capable of reassorting with TX/96 and
produces a greater variety of viral genotypes than NC/02 and TX/96. When genotyping
96 potential reassortant viruses, we identified 34 different reassortant viruses between
MN/99 and TX/96 compared to only 19 reassortant genotypes between NC/02 and
TX/96. However, 21% of the reassortants between MN/99 and TX/96 were only detected
once, while only 10% of the reassortants between NC/02 and TX/96 were detected once.
This suggests that although MN/99 reassorts more frequently than NC/02, many of the
reassortants have relatively slower growth characteristics compared to the parental strains
or other more prevalent reassortant genotypes. The different reassortant genotypes with
the TX/96 HA and NA suggest there may be some gene incompatibility when comparing
MN/99 and NC/02. On the classical swine backbone, both the TX/96 HA and NA occur
together in 68.8% of the reassortants compared to only 18.8% of the reassortants on the
TRIG backbone. Additionally, the TX/96 HA and NA occur alone only 10.8% and
12.9%, respectively, on the classical swine backbone. Conversely, the TX/96 HA alone
occurs 69.8% of the time on the TRIG backbone with the NA from NC/02 producing an
H3N1 genotype. This particular genotype has been identified in swine but at very low
frequencies suggesting this is a favorable genetic composition but it may be limited in its
ability to infect in vivo or to transmit. These statistics are not conclusive for gene
compatibility, but they suggest that the classical HA or NA is incompatible with the TX
HA or NA, while the TX/96 HA appears frequently with the NC/02 NA suggesting they
are highly compatible. There may also be some restrictions based on the different
polymerase segments. In reassortant viruses with the H3 between MN/99 and TX/96,
44.3% of the viruses contained all three polymerase segments from the human lineage
virus while 55.7% contained at least one segment from MN/99 and one segment from
TX/96. Similarly, 53.1% of the reassortant H3 viruses between NC/02 and TX/96
contained at least one polymerase gene segment from NC/02 and at least one segment
from TX/96. However, only 4.5% of the H3 viruses had all three gene segments from
TX/96 and 46.9% had all three gene segments from NC/02. These percentages clearly
demonstrate that the wholly NC/02 polymerase complex is more promiscuous in its
ability to form viable viral genotypes with human H3 gene segments compared to the
MN/99 polymerase gene segments.
There are very few gene segments that very strongly correlate as would have been
expected if there were major gene incompatibilities. The strongest gene segment
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correlation between MN/99 and TX/96 was between the M and NS segments. This is
likely because the matrix protein interacts with the NEP protein as the RNPs are exported
out of the nucleus for virion formation. This interaction is crucial for new budding virions
to completely form as well as for efficient replication.
There are several strongly correlated gene segments between NC/02 and TX/96
including, M and PA and M and NP. The correlation between M and NP likely plays a
role in RNP export from the nucleus as well as viral packaging. The M and NP need to be
able to efficiently interact because it has been suggested that this is a mechanism of
“sensing” when all 8 gene segments have been incorporated into a new virion prior to
budding. This correlation between M and PA is not well understood because there is no
known interaction between the M and PA proteins. This may suggest that there is a
protein interaction that has yet to be identified between the matrix and PA proteins.
Early Kinetic Differences in MDCK Cells
To determine if gene incompatibility was the driving factor for lack of observed
reassortment between classical swine viruses with human HA and NA versus TRIG
viruses, the growth kinetics were completed to compare the parental strains with the 6+2
reassortant viruses. There were no differences observed between the MN/99 parental
strain when compared to the MN/TX virus. Similarly, there was no observable difference
between NC/02 and NC/TX. This demonstrates that addition of the human HA and NA
on the different swine backbones does not attenuate either virus and therefore was not the
limiting factor for the epidemiologic observations in which the classical swine viruses did
not reassort.
The primary differences observed were between 10 to 24 hpi when comparing
TX/96, NC/02, and NC/TX to the kinetics of MN/99 and MN/TX. MN/99 and MN/TX
showed significantly lower titers at 10, 12, 20, and 24 hpi when compared to the NC/02
virus. This indicates that NC/02 and NC/TX have distinct growth advantages in the
ability to initiate an infection and spread within the host when compared to MN/99 and
MN/TX. This further suggests why the TRIG viruses have displaced the classical swine
viruses, but does not provide evidence for the lack of classical swine virus reassortment.
To further explore if the polymerase gene segments affect genetic compatibility,
multiple polymerase reassortants were rescued and growth kinetics were completed.
Again, TX/96 and NC/TX proved to be the most fit kinetically out of the viruses tested.
The other significant differences occurred when the TRIG PB2 and/or PA gene segments
were rescued in the MN/TX virus. Unexpectedly, the polymerase reassortants with the
TRIG PB2 and PA show reduced fitness suggesting that they may not be fully compatible
with the cs PB1. Despite the observed differences, they only occur at the later time points
of 24 through 48 hpi and do not occur during the full time course. Within this model, the
addition of the TRIG PB2 and/or PA does not confer any growth advantage to MN/TX.
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Not only do the polymerase gene segments need to be well matched for efficient
replication, even the NS1 and/or NEP proteins need to be matched with the other gene
segments. The inclusion of TRIG NS in the MN/TX virus also disrupts viral growth
efficiency. However, the effects are only noticeable between 12 and 24 hpi, as the end
point viral titers are not different from the other tested viruses. This demonstrates a clear
polygenic cooperation in these viruses when tested in MDCK cells.
RG Virus Growth Kinetics in pSRECs
The growth kinetics in MDCK cells indicate that TX/96 grows more rapidly than
either MN/99 or NC/02. However, other studies have shown that TX/96 does not
efficiently replicate in swine,66 suggesting that the MDCK model is not adequate for
swine virus studies. Preliminary growth kinetics in pSRECs from laboratory pigs
mirrored previous studies in which the TX/96 virus grew at lower titers than either of the
swine viruses. Additionally, the reassortant MN/TX and NC/TX viruses grew to similar
titers as MN/99 and NC/02.
Despite the promising results of the initial studies, when the growth kinetics were
repeated in pSRECs derived from naturally farmed swine, there were no kinetic
differences between any of the viruses except TX/96 and MN/99 at 20 hpi. These
differing results can be explained by several factors. The use of primary cells from
varying sources can lead to inconsistent results as seen here. Additionally, the pSRECs
used for the initial studies included epithelial cells from beyond the bronchi bifurcation
and included some bronchioles. The later experiments only used cells harvested from the
trachea. It is possible that these factors could have contributed to a differing receptor
expression patterns on the cells used, although, the upper and lower respiratory tracts of
swine predominantly express α2,6 linked sialic acids.82 It is also possible that the pigs
used for the latter experiments had previous exposure to influenza viruses and may have
had some preexisting immunity that was present during the experiment.
Further growth kinetics were completed to determine if the reassorted polymerase
complex had any effects on viral growth in the pSRECs. Similar to growth kinetic results
in MDCK cells, there are identified time points where the viral kinetics were significantly
different, but no viruses showed consistent attenuation when compared to the other tested
viruses. One genotype that matched the results seen in MDCK cells was MN/TX/NCPB2 PA. This virus grew at significantly lower titers at 12-20 hpi compared to MN/TX.
Furthermore, when the whole TRIG polymerase complex is rescued in the MN/TX virus,
the virus is no longer attenuated. This strongly suggests that the polymerase complex
must be well matched for efficient replication and that the TRIG PB2 and PA do not
efficiently interact with the classical swine PB1.
When the TRIG NS is rescued in the MN/TX virus, there is no significant
difference observed in the growth kinetics using pSRECs, however, the MN/TX/NC-NS
virus does show some slight attenuation 10-20 hpi. This is different than what was seen in
MDCK cells in which the MN/TX/NC-NS virus was significantly attenuated. This
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suggests that introduction of the TRIG NS causes some incompatibility but this
incompatibility can be overcome in the swine cells. One possible explanation for
overcoming the incompatibility in the pSRECs is that the TRIG NEP more specifically
interacts with swine CRM1 than canine CRM1 thereby reducing the effect of a new gene
segment. CRM1 has been shown to mediate protein export from the nucleus and is
conserved among species.
Swine Backbones Restore Transmission in Vivo
Pigs were infected with the wt TX/96 and the reverse genetic NC/TX, MN/TX,
and MN/TX/NC-PB1 viruses to test the ability of swine viruses with human H3 and N2
surface glycoprotein to infect and transmit. As expected, TX/96 did not transmit to any of
the contact animals despite establishing an infection in the directly inoculated animals.
One of the inoculated animals did not have a titer on day 3 but had titers on 1 and 5 dpi.
This was likely the result of poor swabbing. The virus was cleared by both infected
animals by day 7 post infection.
Similarly, when MN/TX/NC-PB1 was used for inoculation, the two inoculated
animals became infected and all three contact animals remained negative throughout the
experiment. However, both MN/TX and NC/TX were able to transmit to 100% of the
contact animals. This indicates that disruption of the MN polymerase complex with the
TRIG PB1 causes a decrease in viral growth as well as diminishes its ability to transmit.
Most surprising is the ability of the MN/TX and NC/TX viruses to transmit to all
contact animals. The MN/TX virus appeared in contact animals starting 3-5 dpi and was
detected for about 6 days prior to clearance. The duration of viral shedding and peak
titers were similar between inoculated and contact animals. This provides compelling
evidence that HA and NA are not the primary host determinant factors, but rather the
interaction of the internal gene products with each other and with host proteins. However,
this experiment cannot rule out a virus’ inability to infect a host due to poor receptor
recognition.
Additionally, NC/TX 6+2 showed similar growth characteristics to MN/TX.
NC/TX transmitted to all three contact animals starting 3-5 dpi and could be detected for
4-6 days prior to clearance. Inoculated animals had similar peak titers to contact animals
and these peak titers were also comparable to those seen with MN/TX. However, NC/TX
appears to reach peak titers 1 to 2 days before MN/TX. The pigs inoculated with NC/TX
peaked 1 dpi and the contact animals reached peak titers 3-5 days post inoculation. The
peak titers of MN/TX were delayed 1-2 days when compared to NC/TX in that the
inoculated animals reached peak titers 3 dpi and the contact animals reached peak titers
5-7 dpi. This indicates that the TRIG backbone provides an inherent growth advantage
because the TRIG viruses can reach peak titers more rapidly and therefore establish a
productive infection prior to the viruses with the classical swine backbone.
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Conclusions
The success of influenza viruses with the TRIG cassette is difficult to dispute due
to the high epidemiologic prevalence in U.S. swine herds. This success can be attributed
to the virus’ ability to rapidly establish an infection when compared to the classical swine
viruses. However, incorporating the TRIG polymerase heterotrimer into the classical
swine virus does not confer this rapid viral replication phenotype suggesting that the
growth advantage seen in the TRIG viruses is a trait inferred by the other segments or
optimized gene and protein interactions. It does lend evidence for why the TRIG viruses
displaced the classical swine viruses, but cannot provide an answer for how reassortment
was restricted in classical swine viruses. The data suggests that there is no virologic
reason for why the classical swine viruses did not reassort because they are capable in in
vitro experiments. In vivo experiments also demonstrated that the human H3 and N2
segments were capable of infecting and transmitting. This indicates that there are other
factors, including host and environmental, that caused the epidemiologically observed
differences in reassortment between the TRIG viruses and classical swine viruses.
The HA and NA are regarded as the main contributors of host restriction.
However, when rescued on different backbones, the same viral glycoproteins can show
transmissible phenotypes and restricted phenotypes. This suggests that host restriction
can also be attributed to some aspects of the internal genes. This data only confounds the
questions further as to why no reassortants were seen with the classical swine virus
backbone.
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CHAPTER 4.

EVOLUTIONARY BURST OF REVERSE GENETIC VIRUSES
PASSAGED IN SWINE EPITHELIAL CELLS
Introduction

The classical swine HAs underwent minimal antigenic drift during roughly 80
years of circulation in U.S. swine herds. This is largely the result of minimal immune
pressure due to the limited life span of farmed swine as well as the continual introduction
of young naïve piglets for growing and finishing.62 However, once the TRIG cassette
formed within the swine viruses, there was a considerable increase in genetic
reassortment as well as increased genetic drift.63 The increased genetic variation has yet
to be fully explained.
Several hypotheses have been proposed for why the TRIG provides this
evolutionary burst, but they have not been extensively examined experimentally as of yet.
The increased growth kinetics resulting from the optimized polymerase complex could
afford greater statistical probability that a virus with beneficial mutations would arise and
be capable of becoming the dominant viral species within the population, thus
transmitting to new hosts. The RNA dependent RNA polymerase complex is inherently
inaccurate during replication, so more virus progeny are produced increasing the
probability of successful variants. Another possibility is that the TRIG NS provides an
initial growth advantage for the virus by greater suppression of the host interferon
response (P. Thomas, personal communication, October 13, 2010). This early burst of
replication may provide an opportunity for increased viral variants, some of which may
have advantageous mutations. Where more research is needed, recent computational
modeling reveals that viruses containing the TRIG cassette as well as the TRIG NS
appear to undergo accelerated nucleotide substitution when compared to viruses that lack
these internal genes.83 The epidemiologic data and phylogenetic analysis suggests there is
a strong relationship between the TRIG cassette and NS leading to increased evolution of
the HA and the virus as a whole. The increased propensity for reassortment and the
evolutionary burst could have significant implications for influenza evolution, host
adaption, and human health.
The increased promiscuity of the TRIG polymerase complex increases the
possibility of incorporation of novel HAs on the TRIG backbone as well as the ability to
more readily adapt to a new host. This has important implications for agricultural health
especially if more virulent viruses are able to reassort with the TRIG and transmit among
the pig population. This scenario also poses serious implications for public health. With
the emergence of the TRIG in the human population during the 2009 H1N1 pandemic,
the opportunities of reassortment with novel avian and highly pathogenic avian HAs has
increased. Along with the risk that these novel HAs can more readily adapt to the human
host receptors raising the likelihood for sustained transmission. Additionally recent
studies have indicated that as few as five mutations are required for highly pathogenic
H5N1 viruses to transmit via aerosol contact between ferrets.84,85 The evolutionary
characteristics of the TRIG cassette and TRIG NS need to be further investigated in order
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to better understand how influenza viruses will continue to evolve and the risks posed to
swine and human health.
Material and Methods
Viruses
Multiple reverse genetics viruses were rescued based around the RG-MN/99
classical swine H1N1 virus, the RG-NC/02 triple reassortant H1N1 virus, and TX/96
human H3N2 virus. The RG viruses were generated using the dual promoter eight
plasmid system as outlined in Figure 2-1.70 The rescued virus supernatants were then
injected into 10 day old embryonated chicken eggs and incubated at 35°C for 48 hours.
The allantoic fluid is harvested and re-injected into embryonated chicken eggs for a
second passage. The virus was harvested, aliquoted, and stored at -80°C. Each vial was
only thawed once before use in each experiment. All of the genotypes used for the viral
passage experiments are identified in Table 3-1.
Viral Passaging in pSRECs
The pSRECs were grown on collagen coated tissue culture plates to about 80-90%
confluence and the cells were washed with 1X PBS. The HA titer was determined for
each virus using 0.5% (v/v) turkey red blood cells. Prior to infecting the cells, each virus
was diluted to an HA unit of 1 (the minimal amount of virus required to prevent
agglutination of red blood cells), in a total of 3 ml of infection media. The pSRECs were
then infected with 1 ml of the virus dilution and incubated at 37°C with 5% CO2 for 1
hour. The viral dilutions were then washed from the cells using 1X PBS and infection
media with 0.5 µg/ml TPCK-Trypsin.
The cells were monitored daily for cytopathic effect (CPE). CPE is change in
observable cellular morphology resulting from infection or natural cell death. When the
cells reached a CPE score of 2-3, the viral supernatant was collected and a 1 ml aliquot
was stored at -80°C and the HA titer was determined using a portion of the remaining
volume. The viruses were again diluted to an HA titer of 1 and used to infect a new 8090% confluent well of pSRECs. If there was no detectable HA titer, the virus was diluted
at 1:8 and this dilution was used for pSREC infection. This process was repeated for a
total of 6 viral passages.
Viral Sequencing
To determine a relative nucleotide substitution rate, the HAs of the cell-1 (C1)
passage, egg-1 (E1) passage, and egg-2 (E2) passage of each rescued virus were all
sequenced using the MiSeq Illumina platform as described in chapter 3 using the Bioo
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Scientific NEXTflex sequencing kits (catalog number 5140-02). Nucleotide variations
were determined using the CLC Genomics Workbench 6.0.1 quality-based variant
detection algorithm.
Results
Viral Passaging in pSRECs
We observed a decline of HA titers for several viruses over the course of the
initial viral passaging experiment. The classical swine virus with the TRIG PB2 and PA
showed a gradual decrease from an HA titer of 64 at viral passage (vPx) 2 to a titer of 16
at vPx 4 (Figure 4-1A). This was similar to NC/TX/MN-PB1 which the HA titer had
decreased from 64 to 32 in vPx 2 to a titer of 0 by vPx 4. Numerous viruses resulted in an
HA titer of 0 by the fourth passage, including MN/TX, TX/96, MN/TX/NC-NS, and
MN/TX/NC-PB1. The only virus that maintained a relatively stable HA titer was NC/TX
with a titer of 64 for all 4 passages. All of the viruses that maintained an HA titer through
four passages, had an avian PB2 and/or PA gene segment constellation in the polymerase
complex, except for NC/TX/MN-PB1 (Table 4-1).
To confirm that the reduction in HA titer was not a random occurrence, the
passaging experiment was repeated and all viruses were passaged 6 times in the pSRECs
even if the HA titers dropped below detectable levels. Like the previous experiments,
NC/TX maintained an HA titer for all 6 passages, although the titers did decrease at vPx
2 and increased to a titer of 128 by vPx 5 (Figure 4-1B). As with the first trial, many of
the viruses showed decreasing titers around vPx 4, however, after continuing passaging
within the pSRECs, viruses recovered titers including MN/99, MN/TX/NC-NS,
MN/TX/NC-PB1, and MN/TX/NC-PA. Despite a similar pattern of HA titer decrease and
recovery, only 2 viruses showed this commonality between the 1st and 2nd experiments
(Table 4-2). Unexpectedly, NC/02 showed a decreasing titer through vPx 3 and did not
recover.
Surprisingly, when TCID50 titers were determined for all of the viruses from the
first experiment, all of the viruses maintained TCID50 titers for all passages except
MN/TX/NC-PB1 which had no detectable titer after the 4th passage (Figure 4-2). Even
more interesting is that as the HA titers were decreasing up to passage 4, the infectivity
titers were all increasing from passage 3 to 4.
TRIG NS Evolutionary Burst
Deep sequencing data of the human H3 on the classical swine backbone, TRIG
backbone, and classical swine with TRIG NS revealed very few nucleotide substitutions.
There was one nucleotide substitution identified in the H3 on the classical swine
backbone at position 1179 from the C1 to the E1 passage (Figure 4-3A and Table 4-3).
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Figure 4-1: HA titers of viruses during passaging within pSRECs
A) Shows HA titer over the course of viral passages in the pSRECs up the passage 4. B)
Shows HA titers for a 2nd experiment over the course of 6 viral passages in the pSRECs.
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Table 4-1:

Viral genotypes and gene constellations for pSREC passage

Virus

PB2

PB1

PA

HA

NP

NA

M

NS

NC/TX

NC

NC

NC

TX

NC

TX

NC

NC

MN/TX

MN

MN

MN

TX

MN

TX

MN

MN

TX/96

TX

TX

TX

TX

TX

TX

TX

TX

MN

MN

MN

TX

MN

TX

MN

NC

MN

NC

MN

TX

MN

TX

MN

MN

NC

MN

NC

TX

NC

TX

NC

NC

NC

MN

NC

TX

MN

TX

MN

MN

NC

MN

MN

TX

MN

TX

MN

MN

MN

MN

NC

TX

MN

TX

MN

MN

MN/TX/NCNS
MN/TX/NCPB1
NC/TX/MNPB1
MN/TX/NCPB2 PA
MN/TX/NCPB2
MN/TX/NCPA

The orange boxes symbolize gene segments sourced from the TRIG virus NC/02, Blue
boxes indicate gene segments of classical swine lineage and the green boxes are genes
from the human H3N2 virus, TX/96. The yellow highlighted RG viruses maintained HA
titers through the 4 pSREC passages. The viruses with no color had an HA titer crash
with no recovery.
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Table 4-2:
Viral genotypes and gene constellations for pSREC passaging after 6
viral passages
Virus

PB2

PB1

PA

HA

NP

NA

M

NS

NC/02

NC

NC

NC

NC

NC

NC

NC

NC

NC/TX

NC

NC

NC

TX

NC

TX

NC

NC

MN/99

MN

MN

MN

MN

MN

MN

MN

MN

MN/TX

MN

MN

MN

TX

MN

TX

MN

MN

TX/96

TX

TX

TX

TX

TX

TX

TX

TX

MN

MN

MN

TX

MN

TX

MN

NC

MN

NC

MN

TX

MN

TX

MN

MN

NC

MN

NC

TX

NC

TX

NC

NC

NC

MN

NC

TX

MN

TX

MN

MN

NC

MN

MN

TX

MN

TX

MN

MN

MN

MN

NC

TX

MN

TX

MN

MN

MN/TX/NCNS
MN/TX/NCPB1
NC/TX/MNPB1
MN/TX/NCPB2 PA
MN/TX/NCPB2
MN/TX/NCPA

The orange boxes symbolize gene segments sourced from the TRIG virus NC/02, Blue
boxes indicate gene segments of classical swine lineage and the green boxes are genes
from the human H3N2 virus, TX/96. The yellow highlighted RG viruses maintained HA
titers through the 6 pSREC passages. The viruses with no color had an HA titer crash
with no recovery.
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Figure 4-2: Infectivity titers of the RG viruses after serial passaging in pSRECs
TCID50 titers determined for RG viruses over the course of 4 passages in pSRECS.
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Figure 4-3: Comparison of quality-based variant detection results between
MN/TX, NC/TX, and MN/TX/NC-NS
A) Nucleotide variant detection for HA of MN/TX passage C1 through E2. The blue
graph indicates HA segment read coverage and the orange bar graph identifies location
and prevalence of variants. B) Nucleotide variant detection for HA of NC/TX passage C1
through E2. The blue graph indicates HA segment read coverage and the orange bar
graph identifies location and prevalence of variants. C) Nucleotide variant detection for
HA of MN/TX/NC-NS passage C1 through E2. The blue graph indicates HA segment
read coverage and the orange bar graph identifies location and prevalence of variants.
The 2 common variants identified on the 5’ and 3’ ends of all data sets include mutations
derived from the universal primers.
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Table 4-3:

Nucleotide position and frequency of detected variants
Virus
passage
C1
E1

E2

MN/TX
Nucleotide
Percent of
position
population
1179

12.66%

462
624
637

16.67%
8%
21.74%

NC/TX
Nucleotide
Percent of
position
population
1177
6.33%
1177
7.55%
1177
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6.06%

MN/TX/NC-NS
Nucleotide
Percent of
position
population
98
13.33%
233
9.09%
1177
6.19%
457
29.03%
458
38.71%
462
8%
463
8.33%
660
9.52%
1177
5.85%

This mutant made up 12.66% of the population but was undetectable from the viral
population in the E2 passage. However, the E2 passage resulted in 3 new nucleotide
mutations compared to the C1 passage at positions 462 (16.67%), 624 (8%), and 637
(21.74%).
Despite the presence of the TRIG NS in the NC/TX virus, through all three virus
passages, only 1 variant was detected (Figure 4-3B). This variant was detected at
nucleotide position 1177. This variant is identified in all 3 passages; however it only
occurs at relatively low frequency, ranging 7.55% at passage E1 to 6.06% at passage E2
(Table 4-3).
Interestingly, when the TRIG NS is rescued on the classical swine backbone and
human H3N2 surface proteins, there seem to be an increased number of nucleotide
mutations. In the C1 passage, 1 variant was detected at position 98 (13.33%) as seen in
Figure 4-3C. By passage E1 the nucleotide variant at position 98 was no longer detected
in the population and was replaced by 2 other variants at positions 233 (9.09%) and 1177
(6.19%). In the E2 passage, the variant at 1177 was maintained in the population at
5.85% and 5 additional variants were detected. The first 4 variants were detected close
together at positions 457 (29.03%), 458 (38.71%), 462 (8%), and 463 (8.33%). The final
variant identified made up 9.52% of the population at position 660 (Table 4-3).
Discussion
Viral Passages in pSRECs Do Not Mirror Nature
The passaging experiments in pSRECs were conducted to determine evolutionary
rates, but some viruses did not have the ability to maintain productive infections through
multiple passages. However, further investigation revealed that although the HA titers
had become undetectable, most of the TCID50 titers were maintained albeit they were
decreasing through passage 3. All of the viruses except MN/TX/NC-PB1 showed
increasing titers from passage 3 to 4. Coincidentally, MN/TX/NC-PB1 also failed to
transmit in the pig experiments. However, when the passaging experiment was repeated,
several viruses showed unexpected HA titer crashes including NC/02, MN/TX/NC-PB2
PA, and MN/TX/NC-PB2. These were unexpected because NC/02 has proven to be
successful in swine and MN/TX/NC-PB2 PA and MN/TX/NC-PB2 were able to maintain
HA titers in the initial experiment. Despite these inconsistencies, the overall HA titer
patterns are similar between both experiments. The titers in general seem to continue to
decrease up to vPx 4 and then in the second experiment many HA titers recover. This
could be an indication of the viruses switching receptor specificities. All of the viruses
used were previously passaged twice in eggs to obtain sufficient viral titers and volumes
for experiments. When used in the pSRECs, the viruses may need to adapt back to the
swine receptors.
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The TRIG NS Does Cause an Evolutionary Burst on the Classical Swine Backbone
Deep sequencing of the TX/96 HA on several different backbones revealed
different nucleotide substitutions. The NC/TX appeared the most stable with a single
nucleotide substitution, at nucleotide position 1177 that appeared in all 3 passages but
remained a relatively small proportion of the population despite being maintained. This
could likely be a complimentary mutation which is matched with one or more mutations
in another segment(s). Interestingly, the nonsynonymous substitution at 1177 or nearby at
1179 appeared in the other viruses as well. The MN/TX virus had 4 nucleotide variants
over the course of the 3 passages suggesting that the virus is more prone to mutation than
NC/TX. This is further supported in that the nucleotide substitution in the E1 passage
becomes undetectable following the E2 passage. These multiple changes indicate a higher
nucleotide substitution rate, but a larger sample size with more passages would be
required to confirm. Finally, MN/TX/NC-NS showed the most nucleotide substitutions in
the TX HA. Through the course of the 3 passages there were 6 total nucleotide variants in
the HA segment. Most of these cause amino acid substitutions in the globular head
around the receptor binding site. This indicates that there is greater instability in the
MN/TX/NC-NS virus compared to the other 2 viruses. But, if it was solely attributed to
the TRIG NS, then an increased number of substitutions should have been detected in the
HA of NC/TX. So, the greater instability in the HA of MN/TX/NC-NS could be the result
of an additional foreign segment. This experiment is largely limited to the number of
passages as well as sequencing limitations. In order to reduce sequencing inaccuracies,
the threshold for variant detection needs to be set high enough to eliminate background
substitutions. This could potentially mask the detection of many other minor variants.
The study also needs an increased number of segments to be sequenced to determine if
the genetic instability is observed in all of the gene segments and try to identify
complimentary mutations.
Conclusions
Initial data suggested that the classical swine virus may not have reassorted in
nature because transmission could not be sustained in swine. However, this trend was not
observed in the later experiments described in this chapter. It is possible that the
experimental passages were not continued long enough for all viruses to reach sufficient
concentration to be detected by the HA assay. The variability of the primary cell model
may also lead to the viral titer crashes observed.
Preliminary studies also support the role of the TRIG NS in viral evolution.
However, it cannot be excluded that the additional reassorted gene segment is responsible
for the increased nucleotide substitutions rather than the TRIG NS itself. Many factors
could be responsible for the increased nucleotide substitution frequencies; however, this
study provides a new technique that can be used to study viral evolution through the
detection of minor variants.
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CHAPTER 5.

GENERAL DISCUSSION, CONCLUSIONS, AND FUTURE
DIRECTIONS

Swine have often been postulated as the primary mixing vessel for the generation
of pandemic viruses because they are a susceptible host for both avian and mammalian
influenza viruses. However, there is no direct link between pigs and the pandemic viruses
from 1918, 1957, and 1968. Prior to the 2009 H1N1 pandemic, the specific pandemic
genotype had not been detected or isolated from swine but following the pandemic, there
have been numerous viruses isolated from swine with the pandemic genotype. There have
also been numerous reassortant viruses isolated from swine with the TRIG cassette.
Swine viruses containing the TRIG cassette have shown increased viral diversity since
the TRIG introduction around 1998. This is in stark contrast to the swine virus stability
observed for the roughly 80 years prior to the TRIG formation. This study set out to
determine what virologic mechanisms are responsible for the promiscuity of the TRIG or
what restrictions are present in the classical swine viruses that prevented reassortment.
The data presented in this dissertation suggests that there is no distinct virologic
factor that prevented the classical swine viruses from reassorting compared to the TRIG
viruses. As found in many of the experiments, there were trends to suggest that MN/99
was slightly less adept at reassorting when compared to the NC/02. The numerous small
differences observed do suggest that MN/99 cannot reassort as readily as NC/02. This
phenomenon can also be explained by the transition from traditional pig farming to
intensive farming that occurred starting in the late 1980s to the late 1990s. Traditional pig
farming entailed relatively small farms which raised pigs from birth to market with
limited movement between different herds. Intensive farming consists of very large farms
with specialized functions. The pigs are farrowed and weaned at one farm and then
transferred to another farm for growing and in some instances transferred again for
finishing prior to being sent to market. Intensive farming leads to significantly more
opportunities for pigs from different farms to interact at the different stages of growth,
and these interactions increase the possibility for different influenza viruses to transmit
among the herds and reassort.
The data shows that the classical swine virus and TRIG virus are able to
superinfect cells with the human H3N2 virus, albeit, the classical swine virus does show a
reduced number of superinfected cells. The results also indicate that the classical swine
viruses are capable of reassortment similarly to the TRIG virus however, when the
classical virus was grown with gene segments from the TRIG, it is slightly attenuated.
This could be explained by the previous 80 years of evolution. These classical swine
viruses were stable for so long because they had optimized their genetic composition.
Ultimately, the generation of the TRIG resulted in viruses with a significant growth
advantage over the classical swine viruses resulting in its ability to supplant the classical
viruses as the dominant viruses in U.S. swine herds.
Unexpectedly, not all of the cells were infected during the flow cytometry
superinfection experiment. This indicates that there are additional mechanisms preventing
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cellular infection that could also be preventing superinfection other than NA expression.
It is possible that the uninfected cells are in an IFN induced antiviral state; however,
MDCK cells do not produce a very robust IFN response. It is also possible that DI
particles are being produced by these viruses and these interfering particles are reducing
the viral efficiency to infect all of the cells. To test these scenarios, the experiment should
be repeated with IFN incompetent cells to prevent naïve cells from entering an antiviral
state. Additionally, a fluorescent in situ hybridization assay can be performed to identify
if the uninfected cells contain any viral segments. This would provide evidence of DI
particle interference by entering the cell but not establishing a productive infection. The
viral supernatant could also be used for next generation sequencing to identify if any viral
populations contain deletions leading to DI particle formation.
None of the data suggested that the TRIG was more capable of reassorting than
the classical swine virus, however, the in vitro reassortment data shows that the
reassortants generated with the TRIG virus tend to be more fit than those generated with
the classical swine virus. Despite this, there were unexpected results. The most prevalent
viral genotype detected (34.4%) between the TRIG and H3N2 virus was an H3N1 virus
on the TRIG backbone. The first H3N1 viruses were isolated from swine around 2004
and the prevalence has been very low. This is contradictory to what is seen in vitro. This
suggests that the H3N1 genotype is a favorable gene composition; however, the virus
may have difficulty transmitting. To determine the optimal genotypes for infectivity and
transmission, the in vitro reassortment viral supernatant should be used to inoculate naïve
pigs with contacts. The results would suggest what viral genotypes are optimal for
infection and transmission. Additionally, it will indicate if the H3N1 viral genotype is
hindered in its ability to transmit because a large percentage of the inoculating virus will
consist of this H3N1 virus.
Another major finding of this project is the role that the internal gene segments
play in viral transmission. The in vivo transmission experiment clearly demonstrates that
the TX/96 virus is not capable of transmitting in pigs, but when the HA and NA from the
TX/96 virus are rescued on the swine virus backbones, these reverse genetics 6+2 viruses
are capable of transmitting among pigs. This could have significant consequences if the
viral backbone can also allow avian HA and NA combinations to infect and transmit in
mammalian hosts, especially because pigs and humans are immunologically naïve to
many subtypes of influenza viruses. The increased transmissibility of different HA and
NA gene segments needs to be further explored, especially by rescuing avian viral
surface glycoproteins on the different swine virus backbones. Additionally, the viruses
that are capable of transmission can be sequenced to compare whether the avian HAs
mutate to preferentially bind to mammalian receptors, or if the internal gene segments
can overcome this barrier.
Although this study shows the increased fitness of viruses with the TRIG cassette
compared to viruses based on the classical swine backbone, it is narrowed by the use of
mammalian adapted viral surface glycoproteins. It will be important to further study the
ability of the TRIG to reassort with avian lineage HA and NA gene segments.
Additionally, it will be important to look at the ability of these viruses to adapt to

72

mammalian type receptors. Some preliminary data suggests that the TRIG virus with
novel glycoproteins is relatively stable, but this needs to be further analyzed due to the
very limited number of viruses sampled. This would also benefit from analyzing the
number of changes that occur in avian origin HA and NA gene segments on the different
backbone in a mammalian model. This data will help to better model the adaptation rate
if the avian HA and NA glycoproteins were to cross the species boundary on the TRIG
backbone. These experiments also demonstrate that the incorporation of the TRIG NS
does increase the number of nucleotide changes in the HA gene segment around the
receptor binding domain compared to not having a new gene segment. The initial
hypothesis was that the TRIG NS was more efficient at inhibiting the IFN response
leading to increased viral replication and diversity. This has since been shown to not be
correct and that the TRIG virus evades the innate response by some other mechanism.
Due to this information and the observed results, I believe that the increased nucleotide
substitution rate is the result of a foreign gene segment rather than specifically the TRIG
NS. The phylogenetic data shows an evolutionary burst, but all of the viruses undergoing
the burst are identified with at least one gene segment from a different virus. If a different
gene segment other than the TRIG NS was rescued in the MN/TX virus, it would also
likely cause increased nucleotide substitutions as well. The introduction of these
genetically different gene segments likely causes a disruption of certain protein-protein
interactions leading to destabilization of the genome. It remains unclear as to whether this
destabilization is spread throughout the genome equally or if there are particular proteins
that undergo increased nucleotide substitution rates. Further experiments should look at
substitutions throughout the genome when different gene segments are introduced to
pinpoint if any of the 8 segments plays more of a role in the observed evolutionary burst
as well as to determine if the whole influenza virus genome undergoes the evolutionary
burst.
Viruses with the TRIG cassette not only have become the predominant viral
genotypes in swine, but with the 2009 pandemic, the TRIG backbone has become one of
the predominant viral genotypes in humans as well. This is of particular concern, because
the TRIG has shown that it is capable of reassorting frequently and it has acquired novel
HA and NA gene segments in its relatively short evolutionary history. Additionally, data
presented here suggests that host restriction can be overcome by the internal gene
cassette, whether it is based on the classical swine backbone or the TRIG cassette. With
the current dominance of the TRIG in viruses isolated from both swine and humans, the
possibility of reassorting with novel surface glycoproteins is greatly enhanced.
Not only does the TRIG show a promiscuous history, but data in this study show
that it has the ability to rapidly establish an infection and transmit rapidly. This could
easily explain why the 2009 pandemic virus was able to circulate globally in such a short
period of time. This characteristic poses a serious problem for agricultural health and
public health. If it does acquire novel viral glycoproteins of increased pathogenicity, it
will be able to infect a larger proportion of the population prior to its detection and
control which could result in significantly more morbidity and mortality than slower
growing viruses.
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Finally, this study demonstrates that host restriction is clearly a polygenic
characteristic that needs to be further explored. The TRIG provides a backbone that has
the proven ability to reassort and grow with HA and NA surface proteins from different
lineage viruses. It has also proven that it can infect and rapidly transmit in the human and
swine populations. This provides an ideal combination for further generation of novel
genotypes that can enter the human population, quickly adapt, and rapidly circulate. This
study provides the foundation of how the TRIG backbone has become so dominant in
influenza viruses today, but suggests that much more work needs to be conducted to
identify what unique traits give it its evolutionary advantage. This study also
demonstrates that although the viruses have some differences in their abilities to reassort,
the ecology of the hosts also plays a significant role in viral reassortment and evolution.
These traits will help drive increased influenza evolution in humans and swine
throughout the U.S. and the world. Therefore, influenza A surveillance in both swine and
humans needs to be continued to identify the emergence of novel viruses before they
become a public health and agricultural problem.
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APPENDIX A. ANTIBODY PURIFICATION FROM ASCITES FLUID
1) Delipify the ascites fluid
a. Use 1g Liposorb per 25ml ascites at 1-5 mg/ml (Calbiochem #524371
PHM-L Liposorb Absorbent) to bind lipoproteins in the sample (1g will
bind > 50 mg lipoprotein)
b. Incubate at 4°C 1 hour to overnight
c. Centrifuge at 1000 x g for 5 min
d. Pipet ascites into new tube
2) Dilute ascites
a. Dilute delipified ascites fluid to 1:50 (add 49ml 1XPBS to 1ml ascites)
b. Filter diluted ascites through a 0.2μm filter to remove any remaining
liposorb
3) Bind antibody to Protein G column
a. Use a 1ml HiTrap Protein G column (GE Healthcare #17-0404-01 1ml
HiTrap Protein G HP column) Avoid air bubbles in column by filling top
nozzle with liquid and then secure syringe connector
b. Wash column with 5 column volumes of ddH2O (5ml)
c. Wash column with 5 column volumes 1XPBS (5ml)
d. Add 50 ml diluted ascites fluid and pass through filter with 60 ml syringe
(keep all flow through)
e. Wash column with 20 column volumes of 1XPBS (20ml) (Save flow
through)
f. Check optical density (O.D.) absorbance at 280nm (A280) of the flow
through
g. If >0.002 then continue washing with 1XPBS. If <0.002 then elute
antibody. (A280 should be close to 0)
4) Elute antibody
a. In five 1ml tubes add 100μl of 1M Tris-HCl pH 8.0
b. Elute antibody with 5 column volumes (5ml) of 0.1M Glycine-HCl pH 2.7
i. Collect in 1ml fractions in tubes with 100μl of 1M Tris-HCl pH
8.0
c. Invert tubes to neutralize low pH
5) Measure O.D. of fractions
a. Blank spectrophotometer with 1:10 dilution of 1M Tris-HCl pH 8.0 in
0.1M Glycine-HCl pH 2.7 (100μl of 1M Tris-HCl pH 8.0 in 1ml of 0.1M
Glycine-HCl pH 2.7)
b. Measure absorbance of each fraction at 280nm to quantify and determine
purity of purified antibodies
6) Column Storage
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a. Wash column with 10 column volumes (10ml) of 1XPBS
b. Wash column with 10 column volumes (10ml) of ddH2O
c. Add 5 column volumes (5ml) of 20% Ethanol
d. Seal ends of column and store at 4°C
7) Antibody Desalting (Desalt for labeling)
a. Use Zeba desalting column and follow buffer exchange protocol.
Antibody Isotyping (Mouse sourced antibody)
1) Coat 6 wells per antibody of an ELISA plate with antibody target (HA or
disrupted virus)
a. Add 50μl/well of HA or disrupted virus
b. Incubate at 4°C overnight
c. Wash wells 3 times with 1XPBS + 0.05% Tween 20
2) Block wells
a. Block wells with 300μl 1XPBS + 10% FCS (or BSA)
b. Incubate at room temp. for 1 hour
3) Antibody binding
a. Add purified antibody to each well – add 50μl of 1μg/ml
b. Incubate at room temp. for 30 min
c. Wash wells 3 times with 1XPBS + 0.05% Tween 20
4) Secondary Antibody
a. Add 50μl secondary anti-mouse IgG, IgG1, IgG2A, IgG2B, IgG3, and
Neg (can include IgM if expected other than IgG) conjugated antibodies
(1:1000 Alkaline Phosphotase conjugated or 1:5000 HRP conjugated)
b. Incubate for 10 min at room temp.
c. Wash 6 times with 1XPBS + 0.05%Tween 20
d. Add appropriate substrate
i. Expect two positive wells (IgG and Isotype)
Buffers
1) 0.1 M Glycine-HCl, pH 2.7
• 11.1 g Glycine-HCl
• 800 ml dH2O
• Adjust pH to 2.7 with HCl
• Add dH2O to 1L
•
2) 1.0 M Tris, pH 8.0
• 121.1 g Tris
• 700 ml of ddH2O
• Adjust pH to 8.0 with HCl
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•
•

Add ddH2O to 1L
Sterile Filter
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APPENDIX B. ISOLATION AND GROWTH OF PRIMARY SWINE
RESPIRATORY EPITHELIAL CELLS
Isolation of primary swine respiratory epithelial cells
1) Place trachea on sterile 4X4 gauze on Petri dish lid
2) Trim excess tissue from trachea and cut off ends
3) Wash 2-3X in cold PBS
4) Place tissue in 50 ml conical with Pronase/DNAsolution
5) Incubate 48-72 hrs at 4O
2-3 days later
1)
2)
3)
4)

Add 4ml sterile filtered FCS (final concentration 10%)
Invert tube several times
Remove cell suspension with a pipet and place into new 50ml conical
Rinse trachea and tube with 44 ml DMEM/F12, place extra cells in new 50 ml
conical
5) Spin tubes for 10 min at 1200 RPM at 4OC
6) Remove supernatant, resuspend and combine cells from both 50ml conicals in 10
ml of complete media (see complete RE media),
7) Place in a petri dish and incubate 2hrs in 37O incubator (fibroblasts adhere,
epithelial cells do not)
8) Transfer supernatant into a new petri dish and incubate 2hrs in 37O incubator
9) Transfer supernatant into a 50ml conical tube
10) Wash petri dish with DMEM/F12 and add to conical tube
11) Spin tube for 10 min at 1200 RPM at 4O
12) Resuspend cells in 10 ml DMEM/F12
13) Count cells
14) Spin tube for 10 min at 1200 RPM at 4O
15) Resuspend cells in BEGM at a concentration of 1 X 106 cells / ml
16) Place 1 ml in a collagen coated T75 and add 10 ml BEGM
Freeze the remaining cells with 1 ml (1 X 106 cells) per vial
Buffers
1) Ca+ and Mg+ free MEM
(makes 1L)
0.4 g [5.36 mM] KCl
6.4 g [0.1 M] NaCl
3.7 g [44 mM] NaHCO3
0.125 g [0.9 mM] NaH2PO4 ∙ H2O
0.1 mg [0.25 µM] Fe(NO3)3 ∙ 9H2O (Dissolve 10 mg in 10 ml H2O and use 100µl
of this)
4.5 g [25 mM] D-glucose
0.015g [40µM] Phenol Red
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0.110 g [1mM] Sodium pyruvate
Add 950 ml Sterile H2O
pH balance to 7.5
add 10 ml pen/strep and fill to 1L
Filter using 0.2µm filter
Store at 4O C
2) Pronase/DNAsolution
56 mg Pronase (Roche #165921)
4 mg DNase (sigma DN-25)
40 ml Ca+ and Mg+ free MEM (see Ca and Mg free MEM)
400 µl pen/strep (sigma P-0781)
Mix with stir bar until powder is dissolved
Sterile filter with 0.2µm Filter
Keep on ice
Put 2-3 50ml conical tubes with 40 ml of sterile PBS
3) Complete Respiratory Epithelial (RE) Media
2.5 ml FCS
0.5 mL MEM non essential amino acids (sigma M-7145)
60 µl insulin (UWHC 8917700)
47 ml DMEM/F12 with p/s (5ml/500ml bottle)
Store at 4OC
Growth and propagation of pSRECs
Making collagen
1. In a beaker, add 10mg human placental collagen (type VI, Sigma C7521) to 20ml
sterile H2O
2. Add 40ul glacial acetic acid to the beaker (this helps to dissolve the collagen)
3. Add a stirbar, stir at room temp until collagen is dissolved (30-60 min or so)
4. Dilute collagen 1:10 (ie, add the 20ml mixture to 180ml sterile H2O)
5. Sterile-filter through a 0.2um filter (may take 30-60 min or more)
6. Store at 4C, use for collagen-coating plastic. Can be stored for up to 4 months at
4C.
Coating plastic with collagen
1. Add collagen to tissue culture flasks/plates, leave overnight at room temp to
adhere (or leave for at least 6hr in 37C incubator, for collagen to adhere)
Amount of collagen to add: 6ml per T75 flask
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~500ul per well of 12-well plate
~330ul per well of 24-well plate
2. After collagen has adhered, prep collagen:
-aspirate off the water, leave flasks/plates uncovered in tissue culture hood
until the plastic dries completely (ie, until no liquid is visible on the plastic;
usually takes ~30 min for T75 flasks, ~15 min for plates)
-wash plastic 2X w/ PBS (6ml per T75, 500ul per 12-well, 330ul per 24-well)
-add media (Bronchial Epithelial Growth Medium [BEGM] from Lonza), put in
incubator until use.

Reviving SRECs from LN2
1. Pre-warm 10ml DMEM/F12 (we use Invitrogen’s) and 10ml BEGM
2. Quick-thaw cells in 37C water bath
3. Transfer cells to a 50ml conical tube, very slowly add pre-warmed DMEM/F12
4. Spin for 10min at 1000rpm
5. Resuspend cells in 10ml BEGM, add to the collagen-coated flask
6. Change half of the media after a day or two; cells should be ready to split/plate in
2-3 days

Splitting/plating SRECs
Day 1: collagen coat T75 flasks/12-well plates
Day 2:
1. Take cells out of incubator, aspirate off BEGM
2. Add 4ml trypsin to each T75 flask, return to incubator for 5-6 min (during this
time, make 6ml of DMEM/F-12 + 10% FBS)
3. After trypsinization, stop with DMEM/F-12 + 10% FBS, put cells into 50mL
conical tubes
4. Spin cells for 10min at 1,000rpm
5. Remove supernatant, resuspend cells in exactly 10mL of plain DMEM/F-12
6. Take out 10ul of cells to count by hemocytometer
7. Spin cells for 10min at 1,000rpm (while spinning, count cells)
8. Take off supernatant, resuspend in BEGM for ~200,000cells/ml
9. Add cells to flasks and plates
1.5ml (~300,000 cells) to each T75 flask
0.5ml (~100,000 cells) to each well of 12-well plate
0.25ul (~50,000 cells) to each well of 24-well plate
Day 3
6) Change media.
Typical cycle for using SRECs
Day 1: collagen-coat 1 T75 flask
Day 2: thaw one vial of passage 1 (P1) cells, plate in one T75
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Day 3: media change, collagen-coat 3 T75
Day 4: expand cells, from 1 T75 to 3 T75 (cells are now at passage 2)
Day 5: media change, collagen-coat 1 T75 and 4-6 12-well plates
Day 6: split/plate cells, into T75 (for continuing cell growth) and 12-well plates (for
experiments (cells now at passage 3)
Day 7: media change, collagen-coat 3 T75
Day 8: do the experiments on cells in 12-well plates, expand T75 cells from 1 into 3 T75
(these cells are now at passage 4)
Day 9: media change, collagen-coat 4-6 12-well plates
Day 10: plate cells in 12-well plates for experiments (cells now at passage 5)
Day 11: media change
Day 12: do experiments on passage 5 cells
Notes
-We have also used Lonza’s Small Airway Epithelial Growth Medium (SAGM), but
we use BEGM most of the time
-When drying collagen, ensure that all of the liquid is gone; the cells don’t like
residual acetic acid
-typical 37C, 5% CO2 incubator throughout
-we have typically only used cells up to passage 5 for infectivity/replication
experiments, because we do not want them to differentiate (and it has been shown by
others that after passage 5 cells may differentiate), but cells remain viable past this
point.
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